Corpus
Pmc
Racine
Corpus
Checkpoint
Pmc
Racine
Pmc
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs

Identifieur interne : 000367 ( Pmc/Corpus ); précédent : 000366; suivant : 000368

Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs

Auteurs : Sanjay Batra ; Gayathriy Balamayooran ; Malaya K. Sahoo

Source :

RBID : PMC:7079756

Abstract

Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.


Url:
DOI: 10.1007/s00005-011-0136-z
PubMed: 21786215
PubMed Central: 7079756

Links to Exploration step

PMC:7079756

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
<author>
<name sortKey="Batra, Sanjay" sort="Batra, Sanjay" uniqKey="Batra S" first="Sanjay" last="Batra">Sanjay Batra</name>
<affiliation>
<nlm:aff id="Aff1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Balamayooran, Gayathriy" sort="Balamayooran, Gayathriy" uniqKey="Balamayooran G" first="Gayathriy" last="Balamayooran">Gayathriy Balamayooran</name>
<affiliation>
<nlm:aff id="Aff1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sahoo, Malaya K" sort="Sahoo, Malaya K" uniqKey="Sahoo M" first="Malaya K." last="Sahoo">Malaya K. Sahoo</name>
<affiliation>
<nlm:aff id="Aff1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">21786215</idno>
<idno type="pmc">7079756</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079756</idno>
<idno type="RBID">PMC:7079756</idno>
<idno type="doi">10.1007/s00005-011-0136-z</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000367</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000367</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
<author>
<name sortKey="Batra, Sanjay" sort="Batra, Sanjay" uniqKey="Batra S" first="Sanjay" last="Batra">Sanjay Batra</name>
<affiliation>
<nlm:aff id="Aff1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Balamayooran, Gayathriy" sort="Balamayooran, Gayathriy" uniqKey="Balamayooran G" first="Gayathriy" last="Balamayooran">Gayathriy Balamayooran</name>
<affiliation>
<nlm:aff id="Aff1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sahoo, Malaya K" sort="Sahoo, Malaya K" uniqKey="Sahoo M" first="Malaya K." last="Sahoo">Malaya K. Sahoo</name>
<affiliation>
<nlm:aff id="Aff1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Archivum Immunologiae et Therapiae Experimentalis</title>
<idno type="ISSN">0004-069X</idno>
<idno type="eISSN">1661-4917</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Alcamo, E" uniqKey="Alcamo E">E Alcamo</name>
</author>
<author>
<name sortKey="Mizgerd, Jp" uniqKey="Mizgerd J">JP Mizgerd</name>
</author>
<author>
<name sortKey="Horwitz, Bh" uniqKey="Horwitz B">BH Horwitz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Anto, Rj" uniqKey="Anto R">RJ Anto</name>
</author>
<author>
<name sortKey="Mukhopadhyay, A" uniqKey="Mukhopadhyay A">A Mukhopadhyay</name>
</author>
<author>
<name sortKey="Denning, K" uniqKey="Denning K">K Denning</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Arcavi, L" uniqKey="Arcavi L">L Arcavi</name>
</author>
<author>
<name sortKey="Benowitz, Nl" uniqKey="Benowitz N">NL Benowitz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Arenzana Seisdedos, F" uniqKey="Arenzana Seisdedos F">F Arenzana-Seisdedos</name>
</author>
<author>
<name sortKey="Turpin, P" uniqKey="Turpin P">P Turpin</name>
</author>
<author>
<name sortKey="Rodriguez, M" uniqKey="Rodriguez M">M Rodriguez</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Aydin, C" uniqKey="Aydin C">C Aydin</name>
</author>
<author>
<name sortKey="Sanlioglu, Ad" uniqKey="Sanlioglu A">AD Sanlioglu</name>
</author>
<author>
<name sortKey="Bisgin, A" uniqKey="Bisgin A">A Bisgin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Baeuerle, Pa" uniqKey="Baeuerle P">PA Baeuerle</name>
</author>
<author>
<name sortKey="Henkel, T" uniqKey="Henkel T">T Henkel</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Balamayooran, G" uniqKey="Balamayooran G">G Balamayooran</name>
</author>
<author>
<name sortKey="Batra, S" uniqKey="Batra S">S Batra</name>
</author>
<author>
<name sortKey="Fessler, Mb" uniqKey="Fessler M">MB Fessler</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Baldwin, As" uniqKey="Baldwin A">AS Baldwin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Balkwill, F" uniqKey="Balkwill F">F Balkwill</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Barkett, M" uniqKey="Barkett M">M Barkett</name>
</author>
<author>
<name sortKey="Gilmore, Td" uniqKey="Gilmore T">TD Gilmore</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Batra, S" uniqKey="Batra S">S Batra</name>
</author>
<author>
<name sortKey="Sahu, Rp" uniqKey="Sahu R">RP Sahu</name>
</author>
<author>
<name sortKey="Kandala, Pk" uniqKey="Kandala P">PK Kandala</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Beauparlant, P" uniqKey="Beauparlant P">P Beauparlant</name>
</author>
<author>
<name sortKey="Kwan, I" uniqKey="Kwan I">I Kwan</name>
</author>
<author>
<name sortKey="Bitar, R" uniqKey="Bitar R">R Bitar</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Blank, V" uniqKey="Blank V">V Blank</name>
</author>
<author>
<name sortKey="Kourilsky, P" uniqKey="Kourilsky P">P Kourilsky</name>
</author>
<author>
<name sortKey="Israel, A" uniqKey="Israel A">A Israel</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Boczkowski, J" uniqKey="Boczkowski J">J Boczkowski</name>
</author>
<author>
<name sortKey="Lisdero, Cl" uniqKey="Lisdero C">CL Lisdero</name>
</author>
<author>
<name sortKey="Lanone, S" uniqKey="Lanone S">S Lanone</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Burns, Dm" uniqKey="Burns D">DM Burns</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cai, S" uniqKey="Cai S">S Cai</name>
</author>
<author>
<name sortKey="Batra, S" uniqKey="Batra S">S Batra</name>
</author>
<author>
<name sortKey="Shen, L" uniqKey="Shen L">L Shen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cai, S" uniqKey="Cai S">S Cai</name>
</author>
<author>
<name sortKey="Zemans, Rl" uniqKey="Zemans R">RL Zemans</name>
</author>
<author>
<name sortKey="Young, Sk" uniqKey="Young S">SK Young</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cai, S" uniqKey="Cai S">S Cai</name>
</author>
<author>
<name sortKey="Batra, S" uniqKey="Batra S">S Batra</name>
</author>
<author>
<name sortKey="Lira, Sa" uniqKey="Lira S">SA Lira</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, Fe" uniqKey="Chen F">FE Chen</name>
</author>
<author>
<name sortKey="Ghosh, G" uniqKey="Ghosh G">G Ghosh</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, Lf" uniqKey="Chen L">LF Chen</name>
</author>
<author>
<name sortKey="Mu, Y" uniqKey="Mu Y">Y Mu</name>
</author>
<author>
<name sortKey="Greene, Wc" uniqKey="Greene W">WC Greene</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, W" uniqKey="Chen W">W Chen</name>
</author>
<author>
<name sortKey="Wang, X" uniqKey="Wang X">X Wang</name>
</author>
<author>
<name sortKey="Bai, L" uniqKey="Bai L">L Bai</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Choi, Iw" uniqKey="Choi I">IW Choi</name>
</author>
<author>
<name sortKey="Kim, Dk" uniqKey="Kim D">DK Kim</name>
</author>
<author>
<name sortKey="Ko, Hm" uniqKey="Ko H">HM Ko</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Churg, A" uniqKey="Churg A">A Churg</name>
</author>
<author>
<name sortKey="Zay, K" uniqKey="Zay K">K Zay</name>
</author>
<author>
<name sortKey="Shay, S" uniqKey="Shay S">S Shay</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Collart, Ma" uniqKey="Collart M">MA Collart</name>
</author>
<author>
<name sortKey="Baeuerle, P" uniqKey="Baeuerle P">P Baeuerle</name>
</author>
<author>
<name sortKey="Vassalli, P" uniqKey="Vassalli P">P Vassalli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Conaway, Cc" uniqKey="Conaway C">CC Conaway</name>
</author>
<author>
<name sortKey="Yang, Ym" uniqKey="Yang Y">YM Yang</name>
</author>
<author>
<name sortKey="Chung, Fl" uniqKey="Chung F">FL Chung</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Coussens, Lm" uniqKey="Coussens L">LM Coussens</name>
</author>
<author>
<name sortKey="Werb, Z" uniqKey="Werb Z">Z Werb</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cvek, B" uniqKey="Cvek B">B Cvek</name>
</author>
<author>
<name sortKey="Dvorak, Z" uniqKey="Dvorak Z">Z Dvorak</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Davies, Am" uniqKey="Davies A">AM Davies</name>
</author>
<author>
<name sortKey="Ruel, C" uniqKey="Ruel C">C Ruel</name>
</author>
<author>
<name sortKey="Lara, Pn" uniqKey="Lara P">PN Lara</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Davies, Am" uniqKey="Davies A">AM Davies</name>
</author>
<author>
<name sortKey="Chansky, K" uniqKey="Chansky K">K Chansky</name>
</author>
<author>
<name sortKey="Lara, Pn" uniqKey="Lara P">PN Lara</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Delhase, M" uniqKey="Delhase M">M Delhase</name>
</author>
<author>
<name sortKey="Hayakawa, M" uniqKey="Hayakawa M">M Hayakawa</name>
</author>
<author>
<name sortKey="Chen, Y" uniqKey="Chen Y">Y Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Deng, J" uniqKey="Deng J">J Deng</name>
</author>
<author>
<name sortKey="Miller, Sa" uniqKey="Miller S">SA Miller</name>
</author>
<author>
<name sortKey="Wang, Hy" uniqKey="Wang H">HY Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Denlinger, Ce" uniqKey="Denlinger C">CE Denlinger</name>
</author>
<author>
<name sortKey="Rundall, Bk" uniqKey="Rundall B">BK Rundall</name>
</author>
<author>
<name sortKey="Keller, Md" uniqKey="Keller M">MD Keller</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Devalaraja, Mn" uniqKey="Devalaraja M">MN Devalaraja</name>
</author>
<author>
<name sortKey="Wang, Dz" uniqKey="Wang D">DZ Wang</name>
</author>
<author>
<name sortKey="Ballard, Dw" uniqKey="Ballard D">DW Ballard</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Didonato, Ja" uniqKey="Didonato J">JA DiDonato</name>
</author>
<author>
<name sortKey="Hayakawa, M" uniqKey="Hayakawa M">M Hayakawa</name>
</author>
<author>
<name sortKey="Rothwarf, Dm" uniqKey="Rothwarf D">DM Rothwarf</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Driscoll, Ke" uniqKey="Driscoll K">KE Driscoll</name>
</author>
<author>
<name sortKey="Hassenbein, Dg" uniqKey="Hassenbein D">DG Hassenbein</name>
</author>
<author>
<name sortKey="Howard, Bw" uniqKey="Howard B">BW Howard</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dunn, Sm" uniqKey="Dunn S">SM Dunn</name>
</author>
<author>
<name sortKey="Coles, Ls" uniqKey="Coles L">LS Coles</name>
</author>
<author>
<name sortKey="Lang, Rk" uniqKey="Lang R">RK Lang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Duran, A" uniqKey="Duran A">A Duran</name>
</author>
<author>
<name sortKey="Diaz Meco, Mt" uniqKey="Diaz Meco M">MT Diaz-Meco</name>
</author>
<author>
<name sortKey="Moscat, J" uniqKey="Moscat J">J Moscat</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dutta, J" uniqKey="Dutta J">J Dutta</name>
</author>
<author>
<name sortKey="Fan, Y" uniqKey="Fan Y">Y Fan</name>
</author>
<author>
<name sortKey="Gupta, N" uniqKey="Gupta N">N Gupta</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ea, Ck" uniqKey="Ea C">CK Ea</name>
</author>
<author>
<name sortKey="Baltimore, D" uniqKey="Baltimore D">D Baltimore</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Edelman, Mj" uniqKey="Edelman M">MJ Edelman</name>
</author>
<author>
<name sortKey="Burrows, W" uniqKey="Burrows W">W Burrows</name>
</author>
<author>
<name sortKey="Krasna, Mj" uniqKey="Krasna M">MJ Krasna</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Egan, Lj" uniqKey="Egan L">LJ Egan</name>
</author>
<author>
<name sortKey="Mays, Dc" uniqKey="Mays D">DC Mays</name>
</author>
<author>
<name sortKey="Huntoon, Cj" uniqKey="Huntoon C">CJ Huntoon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Engels, Ea" uniqKey="Engels E">EA Engels</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ertel, A" uniqKey="Ertel A">A Ertel</name>
</author>
<author>
<name sortKey="Eng, R" uniqKey="Eng R">R Eng</name>
</author>
<author>
<name sortKey="Smith, Sm" uniqKey="Smith S">SM Smith</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Faggioni, R" uniqKey="Faggioni R">R Faggioni</name>
</author>
<author>
<name sortKey="Gatti, S" uniqKey="Gatti S">S Gatti</name>
</author>
<author>
<name sortKey="Demitri, Mt" uniqKey="Demitri M">MT Demitri</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fang, X" uniqKey="Fang X">X Fang</name>
</author>
<author>
<name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author>
<name sortKey="Zheng, H" uniqKey="Zheng H">H Zheng</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fimognari, C" uniqKey="Fimognari C">C Fimognari</name>
</author>
<author>
<name sortKey="Hrelia, P" uniqKey="Hrelia P">P Hrelia</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Frantz, B" uniqKey="Frantz B">B Frantz</name>
</author>
<author>
<name sortKey="Nordby, Ec" uniqKey="Nordby E">EC Nordby</name>
</author>
<author>
<name sortKey="Bren, G" uniqKey="Bren G">G Bren</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Frode Saleh, Ts" uniqKey="Frode Saleh T">TS Frode-Saleh</name>
</author>
<author>
<name sortKey="Calixto, Jb" uniqKey="Calixto J">JB Calixto</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ghosh, S" uniqKey="Ghosh S">S Ghosh</name>
</author>
<author>
<name sortKey="May, Mj" uniqKey="May M">MJ May</name>
</author>
<author>
<name sortKey="Kopp, Eb" uniqKey="Kopp E">EB Kopp</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gilmore, Td" uniqKey="Gilmore T">TD Gilmore</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gilmore, Td" uniqKey="Gilmore T">TD Gilmore</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gilmore, Td" uniqKey="Gilmore T">TD Gilmore</name>
</author>
<author>
<name sortKey="Herscovitch, M" uniqKey="Herscovitch M">M Herscovitch</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Giuliani, C" uniqKey="Giuliani C">C Giuliani</name>
</author>
<author>
<name sortKey="Napolitano, G" uniqKey="Napolitano G">G Napolitano</name>
</author>
<author>
<name sortKey="Bucci, I" uniqKey="Bucci I">I Bucci</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Glozak, Ma" uniqKey="Glozak M">MA Glozak</name>
</author>
<author>
<name sortKey="Seto, E" uniqKey="Seto E">E Seto</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Greten, Fr" uniqKey="Greten F">FR Greten</name>
</author>
<author>
<name sortKey="Eckmann, L" uniqKey="Eckmann L">L Eckmann</name>
</author>
<author>
<name sortKey="Greten, Tf" uniqKey="Greten T">TF Greten</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gupta, Sc" uniqKey="Gupta S">SC Gupta</name>
</author>
<author>
<name sortKey="Prasad, S" uniqKey="Prasad S">S Prasad</name>
</author>
<author>
<name sortKey="Reuter, S" uniqKey="Reuter S">S Reuter</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hajjar, Am" uniqKey="Hajjar A">AM Hajjar</name>
</author>
<author>
<name sortKey="Harowicz, H" uniqKey="Harowicz H">H Harowicz</name>
</author>
<author>
<name sortKey="Liggitt, Hd" uniqKey="Liggitt H">HD Liggitt</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Han, S" uniqKey="Han S">S Han</name>
</author>
<author>
<name sortKey="Ritzenthaler, Jd" uniqKey="Ritzenthaler J">JD Ritzenthaler</name>
</author>
<author>
<name sortKey="Zheng, Y" uniqKey="Zheng Y">Y Zheng</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Harant, H" uniqKey="Harant H">H Harant</name>
</author>
<author>
<name sortKey="De Martin, R" uniqKey="De Martin R">R de Martin</name>
</author>
<author>
<name sortKey="Andrew, Pj" uniqKey="Andrew P">PJ Andrew</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hasday, Jd" uniqKey="Hasday J">JD Hasday</name>
</author>
<author>
<name sortKey="Bascom, R" uniqKey="Bascom R">R Bascom</name>
</author>
<author>
<name sortKey="Costa, Jj" uniqKey="Costa J">JJ Costa</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hatada, En" uniqKey="Hatada E">EN Hatada</name>
</author>
<author>
<name sortKey="Nieters, A" uniqKey="Nieters A">A Nieters</name>
</author>
<author>
<name sortKey="Wulczyn, Fg" uniqKey="Wulczyn F">FG Wulczyn</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hayden, Ms" uniqKey="Hayden M">MS Hayden</name>
</author>
<author>
<name sortKey="Ghosh, S" uniqKey="Ghosh S">S Ghosh</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hecht, Ss" uniqKey="Hecht S">SS Hecht</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hein, H" uniqKey="Hein H">H Hein</name>
</author>
<author>
<name sortKey="Schluter, C" uniqKey="Schluter C">C Schluter</name>
</author>
<author>
<name sortKey="Kulke, R" uniqKey="Kulke R">R Kulke</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Henneke, I" uniqKey="Henneke I">I Henneke</name>
</author>
<author>
<name sortKey="Greschus, S" uniqKey="Greschus S">S Greschus</name>
</author>
<author>
<name sortKey="Savai, R" uniqKey="Savai R">R Savai</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hewson, Ca" uniqKey="Hewson C">CA Hewson</name>
</author>
<author>
<name sortKey="Haas, Jj" uniqKey="Haas J">JJ Haas</name>
</author>
<author>
<name sortKey="Bartlett, Nw" uniqKey="Bartlett N">NW Bartlett</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Holmes Mcnary, M" uniqKey="Holmes Mcnary M">M Holmes-McNary</name>
</author>
<author>
<name sortKey="Baldwin, As" uniqKey="Baldwin A">AS Baldwin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ikeda, A" uniqKey="Ikeda A">A Ikeda</name>
</author>
<author>
<name sortKey="Sun, X" uniqKey="Sun X">X Sun</name>
</author>
<author>
<name sortKey="Li, Y" uniqKey="Li Y">Y Li</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Iliopoulos, D" uniqKey="Iliopoulos D">D Iliopoulos</name>
</author>
<author>
<name sortKey="Jaeger, Sa" uniqKey="Jaeger S">SA Jaeger</name>
</author>
<author>
<name sortKey="Hirsch, Ha" uniqKey="Hirsch H">HA Hirsch</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Iordanskiy, S" uniqKey="Iordanskiy S">S Iordanskiy</name>
</author>
<author>
<name sortKey="Iordanskaya, T" uniqKey="Iordanskaya T">T Iordanskaya</name>
</author>
<author>
<name sortKey="Quivy, V" uniqKey="Quivy V">V Quivy</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Isomura, I" uniqKey="Isomura I">I Isomura</name>
</author>
<author>
<name sortKey="Morita, A" uniqKey="Morita A">A Morita</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jeong, Sj" uniqKey="Jeong S">SJ Jeong</name>
</author>
<author>
<name sortKey="Radonovich, M" uniqKey="Radonovich M">M Radonovich</name>
</author>
<author>
<name sortKey="Brady, Jn" uniqKey="Brady J">JN Brady</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jeyaseelan, S" uniqKey="Jeyaseelan S">S Jeyaseelan</name>
</author>
<author>
<name sortKey="Manzer, R" uniqKey="Manzer R">R Manzer</name>
</author>
<author>
<name sortKey="Young, Sk" uniqKey="Young S">SK Young</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jeyaseelan, S" uniqKey="Jeyaseelan S">S Jeyaseelan</name>
</author>
<author>
<name sortKey="Young, Sk" uniqKey="Young S">SK Young</name>
</author>
<author>
<name sortKey="Yamamoto, M" uniqKey="Yamamoto M">M Yamamoto</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jeyaseelan, S" uniqKey="Jeyaseelan S">S Jeyaseelan</name>
</author>
<author>
<name sortKey="Young, Sk" uniqKey="Young S">SK Young</name>
</author>
<author>
<name sortKey="Fessler, Mb" uniqKey="Fessler M">MB Fessler</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Johnson, C" uniqKey="Johnson C">C Johnson</name>
</author>
<author>
<name sortKey="Van Antwerp, D" uniqKey="Van Antwerp D">D Van Antwerp</name>
</author>
<author>
<name sortKey="Hope, Tj" uniqKey="Hope T">TJ Hope</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jones, Mr" uniqKey="Jones M">MR Jones</name>
</author>
<author>
<name sortKey="Simms, Bt" uniqKey="Simms B">BT Simms</name>
</author>
<author>
<name sortKey="Lupa, Mm" uniqKey="Lupa M">MM Lupa</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Joo, Jh" uniqKey="Joo J">JH Joo</name>
</author>
<author>
<name sortKey="Jetten, Am" uniqKey="Jetten A">AM Jetten</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kapetanovic, R" uniqKey="Kapetanovic R">R Kapetanovic</name>
</author>
<author>
<name sortKey="Nahori, Ma" uniqKey="Nahori M">MA Nahori</name>
</author>
<author>
<name sortKey="Balloy, V" uniqKey="Balloy V">V Balloy</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Karin, M" uniqKey="Karin M">M Karin</name>
</author>
<author>
<name sortKey="Ben Neriah, Y" uniqKey="Ben Neriah Y">Y Ben-Neriah</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kato, T" uniqKey="Kato T">T Kato</name>
</author>
<author>
<name sortKey="Delhase, M" uniqKey="Delhase M">M Delhase</name>
</author>
<author>
<name sortKey="Hoffmann, A" uniqKey="Hoffmann A">A Hoffmann</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kiernan, R" uniqKey="Kiernan R">R Kiernan</name>
</author>
<author>
<name sortKey="Bres, V" uniqKey="Bres V">V Bres</name>
</author>
<author>
<name sortKey="Ng, Rw" uniqKey="Ng R">RW Ng</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kim, Hj" uniqKey="Kim H">HJ Kim</name>
</author>
<author>
<name sortKey="Hawke, N" uniqKey="Hawke N">N Hawke</name>
</author>
<author>
<name sortKey="Baldwin, As" uniqKey="Baldwin A">AS Baldwin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kleinert, H" uniqKey="Kleinert H">H Kleinert</name>
</author>
<author>
<name sortKey="Euchenhofer, C" uniqKey="Euchenhofer C">C Euchenhofer</name>
</author>
<author>
<name sortKey="Ihrig Biedert, I" uniqKey="Ihrig Biedert I">I Ihrig-Biedert</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Koay, Ma" uniqKey="Koay M">MA Koay</name>
</author>
<author>
<name sortKey="Christman, Jw" uniqKey="Christman J">JW Christman</name>
</author>
<author>
<name sortKey="Segal, Bh" uniqKey="Segal B">BH Segal</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Koay, Ma" uniqKey="Koay M">MA Koay</name>
</author>
<author>
<name sortKey="Gao, X" uniqKey="Gao X">X Gao</name>
</author>
<author>
<name sortKey="Washington, Mk" uniqKey="Washington M">MK Washington</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Krug, Lt" uniqKey="Krug L">LT Krug</name>
</author>
<author>
<name sortKey="Torres Gonzalez, E" uniqKey="Torres Gonzalez E">E Torres-Gonzalez</name>
</author>
<author>
<name sortKey="Qin, Q" uniqKey="Qin Q">Q Qin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kunsch, C" uniqKey="Kunsch C">C Kunsch</name>
</author>
<author>
<name sortKey="Rosen, Ca" uniqKey="Rosen C">CA Rosen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lancaster, Lh" uniqKey="Lancaster L">LH Lancaster</name>
</author>
<author>
<name sortKey="Christman, Jw" uniqKey="Christman J">JW Christman</name>
</author>
<author>
<name sortKey="Blackwell, Tr" uniqKey="Blackwell T">TR Blackwell</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lara, Pn" uniqKey="Lara P">PN Lara</name>
</author>
<author>
<name sortKey="Koczywas, M" uniqKey="Koczywas M">M Koczywas</name>
</author>
<author>
<name sortKey="Quinn, Di" uniqKey="Quinn D">DI Quinn</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lee, Ji" uniqKey="Lee J">JI Lee</name>
</author>
<author>
<name sortKey="Burckart, Gj" uniqKey="Burckart G">GJ Burckart</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lentsch, Ab" uniqKey="Lentsch A">AB Lentsch</name>
</author>
<author>
<name sortKey="Czermak, Bj" uniqKey="Czermak B">BJ Czermak</name>
</author>
<author>
<name sortKey="Bless, Nm" uniqKey="Bless N">NM Bless</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lernbecher, T" uniqKey="Lernbecher T">T Lernbecher</name>
</author>
<author>
<name sortKey="Muller, U" uniqKey="Muller U">U Muller</name>
</author>
<author>
<name sortKey="Wirth, T" uniqKey="Wirth T">T Wirth</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, Jj" uniqKey="Li J">JJ Li</name>
</author>
<author>
<name sortKey="Oberley, Lw" uniqKey="Oberley L">LW Oberley</name>
</author>
<author>
<name sortKey="Fan, M" uniqKey="Fan M">M Fan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, Zw" uniqKey="Li Z">ZW Li</name>
</author>
<author>
<name sortKey="Chu, W" uniqKey="Chu W">W Chu</name>
</author>
<author>
<name sortKey="Hu, Y" uniqKey="Hu Y">Y Hu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, Yt" uniqKey="Li Y">YT Li</name>
</author>
<author>
<name sortKey="He, B" uniqKey="He B">B He</name>
</author>
<author>
<name sortKey="Wang, Yz" uniqKey="Wang Y">YZ Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Libermann, Ta" uniqKey="Libermann T">TA Libermann</name>
</author>
<author>
<name sortKey="Baltimore, D" uniqKey="Baltimore D">D Baltimore</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lilenbaum, R" uniqKey="Lilenbaum R">R Lilenbaum</name>
</author>
<author>
<name sortKey="Wang, X" uniqKey="Wang X">X Wang</name>
</author>
<author>
<name sortKey="Gu, L" uniqKey="Gu L">L Gu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lim, Jh" uniqKey="Lim J">JH Lim</name>
</author>
<author>
<name sortKey="Ha, U" uniqKey="Ha U">U Ha</name>
</author>
<author>
<name sortKey="Sakai, A" uniqKey="Sakai A">A Sakai</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lin, R" uniqKey="Lin R">R Lin</name>
</author>
<author>
<name sortKey="Gewert, D" uniqKey="Gewert D">D Gewert</name>
</author>
<author>
<name sortKey="Hiscott, J" uniqKey="Hiscott J">J Hiscott</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Liu, X" uniqKey="Liu X">X Liu</name>
</author>
<author>
<name sortKey="Togo, S" uniqKey="Togo S">S Togo</name>
</author>
<author>
<name sortKey="Al Mugotir, M" uniqKey="Al Mugotir M">M Al-Mugotir</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Logeat, F" uniqKey="Logeat F">F Logeat</name>
</author>
<author>
<name sortKey="Israel, N" uniqKey="Israel N">N Israel</name>
</author>
<author>
<name sortKey="Ten, R" uniqKey="Ten R">R Ten</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lu, T" uniqKey="Lu T">T Lu</name>
</author>
<author>
<name sortKey="Jackson, Mw" uniqKey="Jackson M">MW Jackson</name>
</author>
<author>
<name sortKey="Wang, B" uniqKey="Wang B">B Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mabb, Am" uniqKey="Mabb A">AM Mabb</name>
</author>
<author>
<name sortKey="Miyamoto, S" uniqKey="Miyamoto S">S Miyamoto</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Macnee, W" uniqKey="Macnee W">W MacNee</name>
</author>
<author>
<name sortKey="Wiggs, B" uniqKey="Wiggs B">B Wiggs</name>
</author>
<author>
<name sortKey="Belzberg, As" uniqKey="Belzberg A">AS Belzberg</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Marquez, N" uniqKey="Marquez N">N Marquez</name>
</author>
<author>
<name sortKey="Sancho, R" uniqKey="Sancho R">R Sancho</name>
</author>
<author>
<name sortKey="Bedoya, Lm" uniqKey="Bedoya L">LM Bedoya</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mckay, Li" uniqKey="Mckay L">LI McKay</name>
</author>
<author>
<name sortKey="Cidlowski, Ja" uniqKey="Cidlowski J">JA Cidlowski</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mehta, H" uniqKey="Mehta H">H Mehta</name>
</author>
<author>
<name sortKey="Nazzal, K" uniqKey="Nazzal K">K Nazzal</name>
</author>
<author>
<name sortKey="Sadikot, Rt" uniqKey="Sadikot R">RT Sadikot</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Meng, Q" uniqKey="Meng Q">Q Meng</name>
</author>
<author>
<name sortKey="Peng, Z" uniqKey="Peng Z">Z Peng</name>
</author>
<author>
<name sortKey="Chen, L" uniqKey="Chen L">L Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mercurio, F" uniqKey="Mercurio F">F Mercurio</name>
</author>
<author>
<name sortKey="Manning, Am" uniqKey="Manning A">AM Manning</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mercurio, F" uniqKey="Mercurio F">F Mercurio</name>
</author>
<author>
<name sortKey="Zhu, H" uniqKey="Zhu H">H Zhu</name>
</author>
<author>
<name sortKey="Murray, Bw" uniqKey="Murray B">BW Murray</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mercurio, F" uniqKey="Mercurio F">F Mercurio</name>
</author>
<author>
<name sortKey="Murray, Bw" uniqKey="Murray B">BW Murray</name>
</author>
<author>
<name sortKey="Shevchenko, A" uniqKey="Shevchenko A">A Shevchenko</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Meyer, S" uniqKey="Meyer S">S Meyer</name>
</author>
<author>
<name sortKey="Kohler, Ng" uniqKey="Kohler N">NG Kohler</name>
</author>
<author>
<name sortKey="Joly, A" uniqKey="Joly A">A Joly</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Meylan, E" uniqKey="Meylan E">E Meylan</name>
</author>
<author>
<name sortKey="Dooley, Al" uniqKey="Dooley A">AL Dooley</name>
</author>
<author>
<name sortKey="Feldser, Dm" uniqKey="Feldser D">DM Feldser</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mizgerd, Jp" uniqKey="Mizgerd J">JP Mizgerd</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mizgerd, Jp" uniqKey="Mizgerd J">JP Mizgerd</name>
</author>
<author>
<name sortKey="Lupa, Mm" uniqKey="Lupa M">MM Lupa</name>
</author>
<author>
<name sortKey="Kogan, Ms" uniqKey="Kogan M">MS Kogan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mortenson, Mm" uniqKey="Mortenson M">MM Mortenson</name>
</author>
<author>
<name sortKey="Schlieman, Mg" uniqKey="Schlieman M">MG Schlieman</name>
</author>
<author>
<name sortKey="Virudachalam, S" uniqKey="Virudachalam S">S Virudachalam</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mukhopadhyay, A" uniqKey="Mukhopadhyay A">A Mukhopadhyay</name>
</author>
<author>
<name sortKey="Bueso Ramos, C" uniqKey="Bueso Ramos C">C Bueso-Ramos</name>
</author>
<author>
<name sortKey="Chatterjee, D" uniqKey="Chatterjee D">D Chatterjee</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nabel, Gj" uniqKey="Nabel G">GJ Nabel</name>
</author>
<author>
<name sortKey="Verma, Im" uniqKey="Verma I">IM Verma</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nakai, K" uniqKey="Nakai K">K Nakai</name>
</author>
<author>
<name sortKey="Kadiiska, Mb" uniqKey="Kadiiska M">MB Kadiiska</name>
</author>
<author>
<name sortKey="Jiang, Jj" uniqKey="Jiang J">JJ Jiang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Newton, Tr" uniqKey="Newton T">TR Newton</name>
</author>
<author>
<name sortKey="Patel, Nm" uniqKey="Patel N">NM Patel</name>
</author>
<author>
<name sortKey="Bhat Nakshatri, P" uniqKey="Bhat Nakshatri P">P Bhat-Nakshatri</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="N Uessan, Pd" uniqKey="N Uessan P">PD N’Guessan</name>
</author>
<author>
<name sortKey="Temmesfeld Wollbruck, B" uniqKey="Temmesfeld Wollbruck B">B Temmesfeld-Wollbruck</name>
</author>
<author>
<name sortKey="Zahlten, J" uniqKey="Zahlten J">J Zahlten</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nimmerjahn, F" uniqKey="Nimmerjahn F">F Nimmerjahn</name>
</author>
<author>
<name sortKey="Dudziak, D" uniqKey="Dudziak D">D Dudziak</name>
</author>
<author>
<name sortKey="Dirmeier, U" uniqKey="Dirmeier U">U Dirmeier</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Novak, U" uniqKey="Novak U">U Novak</name>
</author>
<author>
<name sortKey="Cocks, Bg" uniqKey="Cocks B">BG Cocks</name>
</author>
<author>
<name sortKey="Hamilton, Ja" uniqKey="Hamilton J">JA Hamilton</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Opitz, B" uniqKey="Opitz B">B Opitz</name>
</author>
<author>
<name sortKey="Puschel, A" uniqKey="Puschel A">A Puschel</name>
</author>
<author>
<name sortKey="Schmeck, B" uniqKey="Schmeck B">B Schmeck</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Pahl, Hl" uniqKey="Pahl H">HL Pahl</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Perkins, Nd" uniqKey="Perkins N">ND Perkins</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Perkins, Nd" uniqKey="Perkins N">ND Perkins</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Perkins, Nd" uniqKey="Perkins N">ND Perkins</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Perkins, Nd" uniqKey="Perkins N">ND Perkins</name>
</author>
<author>
<name sortKey="Gilmore, Td" uniqKey="Gilmore T">TD Gilmore</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Phipps, Jc" uniqKey="Phipps J">JC Phipps</name>
</author>
<author>
<name sortKey="Aronoff, Dm" uniqKey="Aronoff D">DM Aronoff</name>
</author>
<author>
<name sortKey="Curtis, Jl" uniqKey="Curtis J">JL Curtis</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Pikarsky, E" uniqKey="Pikarsky E">E Pikarsky</name>
</author>
<author>
<name sortKey="Porat, Rm" uniqKey="Porat R">RM Porat</name>
</author>
<author>
<name sortKey="Stein, I" uniqKey="Stein I">I Stein</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Pold, M" uniqKey="Pold M">M Pold</name>
</author>
<author>
<name sortKey="Zhu, Lx" uniqKey="Zhu L">LX Zhu</name>
</author>
<author>
<name sortKey="Sharma, S" uniqKey="Sharma S">S Sharma</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Power, Mr" uniqKey="Power M">MR Power</name>
</author>
<author>
<name sortKey="Li, B" uniqKey="Li B">B Li</name>
</author>
<author>
<name sortKey="Yamamoto, M" uniqKey="Yamamoto M">M Yamamoto</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Poynter, Me" uniqKey="Poynter M">ME Poynter</name>
</author>
<author>
<name sortKey="Irvin, Cg" uniqKey="Irvin C">CG Irvin</name>
</author>
<author>
<name sortKey="Janssen Heininger, Ym" uniqKey="Janssen Heininger Y">YM Janssen-Heininger</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Poynter, Me" uniqKey="Poynter M">ME Poynter</name>
</author>
<author>
<name sortKey="Irvin, Cg" uniqKey="Irvin C">CG Irvin</name>
</author>
<author>
<name sortKey="Janssen Heininger, Ym" uniqKey="Janssen Heininger Y">YM Janssen-Heininger</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Quinton, Lj" uniqKey="Quinton L">LJ Quinton</name>
</author>
<author>
<name sortKey="Jones, Mr" uniqKey="Jones M">MR Jones</name>
</author>
<author>
<name sortKey="Simms, Bt" uniqKey="Simms B">BT Simms</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Regnier, Ch" uniqKey="Regnier C">CH Regnier</name>
</author>
<author>
<name sortKey="Song, Hy" uniqKey="Song H">HY Song</name>
</author>
<author>
<name sortKey="Gao, X" uniqKey="Gao X">X Gao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Reuter, S" uniqKey="Reuter S">S Reuter</name>
</author>
<author>
<name sortKey="Prasad, S" uniqKey="Prasad S">S Prasad</name>
</author>
<author>
<name sortKey="Phromnoi, K" uniqKey="Phromnoi K">K Phromnoi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Richardson, Pg" uniqKey="Richardson P">PG Richardson</name>
</author>
<author>
<name sortKey="Hideshima, T" uniqKey="Hideshima T">T Hideshima</name>
</author>
<author>
<name sortKey="Mitsiades, C" uniqKey="Mitsiades C">C Mitsiades</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ritter, C" uniqKey="Ritter C">C Ritter</name>
</author>
<author>
<name sortKey="Andrades, M" uniqKey="Andrades M">M Andrades</name>
</author>
<author>
<name sortKey="Frota Junior, Ml" uniqKey="Frota Junior M">ML Frota Junior</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rodin, Sn" uniqKey="Rodin S">SN Rodin</name>
</author>
<author>
<name sortKey="Rodin, As" uniqKey="Rodin A">AS Rodin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Roebuck, Ka" uniqKey="Roebuck K">KA Roebuck</name>
</author>
<author>
<name sortKey="Rahman, A" uniqKey="Rahman A">A Rahman</name>
</author>
<author>
<name sortKey="Lakshminarayanan, V" uniqKey="Lakshminarayanan V">V Lakshminarayanan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rothwarf, Dm" uniqKey="Rothwarf D">DM Rothwarf</name>
</author>
<author>
<name sortKey="Zandi, E" uniqKey="Zandi E">E Zandi</name>
</author>
<author>
<name sortKey="Natoli, G" uniqKey="Natoli G">G Natoli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Saccani, S" uniqKey="Saccani S">S Saccani</name>
</author>
<author>
<name sortKey="Pantano, S" uniqKey="Pantano S">S Pantano</name>
</author>
<author>
<name sortKey="Natoli, G" uniqKey="Natoli G">G Natoli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sadikot, Rt" uniqKey="Sadikot R">RT Sadikot</name>
</author>
<author>
<name sortKey="Zeng, H" uniqKey="Zeng H">H Zeng</name>
</author>
<author>
<name sortKey="Yull, Fe" uniqKey="Yull F">FE Yull</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sanceau, J" uniqKey="Sanceau J">J Sanceau</name>
</author>
<author>
<name sortKey="Kaisho, T" uniqKey="Kaisho T">T Kaisho</name>
</author>
<author>
<name sortKey="Hirano, T" uniqKey="Hirano T">T Hirano</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sasco, Aj" uniqKey="Sasco A">AJ Sasco</name>
</author>
<author>
<name sortKey="Secretan, Mb" uniqKey="Secretan M">MB Secretan</name>
</author>
<author>
<name sortKey="Straif, K" uniqKey="Straif K">K Straif</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sawa, Y" uniqKey="Sawa Y">Y Sawa</name>
</author>
<author>
<name sortKey="Ueki, T" uniqKey="Ueki T">T Ueki</name>
</author>
<author>
<name sortKey="Hata, M" uniqKey="Hata M">M Hata</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Scagliotti, Gv" uniqKey="Scagliotti G">GV Scagliotti</name>
</author>
<author>
<name sortKey="Germonpre, P" uniqKey="Germonpre P">P Germonpre</name>
</author>
<author>
<name sortKey="Bosquee, L" uniqKey="Bosquee L">L Bosquee</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Scheinman, Ri" uniqKey="Scheinman R">RI Scheinman</name>
</author>
<author>
<name sortKey="Gualberto, A" uniqKey="Gualberto A">A Gualberto</name>
</author>
<author>
<name sortKey="Jewell, Cm" uniqKey="Jewell C">CM Jewell</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Schmeck, B" uniqKey="Schmeck B">B Schmeck</name>
</author>
<author>
<name sortKey="Zahlten, J" uniqKey="Zahlten J">J Zahlten</name>
</author>
<author>
<name sortKey="Moog, K" uniqKey="Moog K">K Moog</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Schmedtje, Jf" uniqKey="Schmedtje J">JF Schmedtje</name>
</author>
<author>
<name sortKey="Ji, Ys" uniqKey="Ji Y">YS Ji</name>
</author>
<author>
<name sortKey="Liu, Wl" uniqKey="Liu W">WL Liu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sen, R" uniqKey="Sen R">R Sen</name>
</author>
<author>
<name sortKey="Baltimore, D" uniqKey="Baltimore D">D Baltimore</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sen, R" uniqKey="Sen R">R Sen</name>
</author>
<author>
<name sortKey="Baltimore, D" uniqKey="Baltimore D">D Baltimore</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shakhov, An" uniqKey="Shakhov A">AN Shakhov</name>
</author>
<author>
<name sortKey="Collart, Ma" uniqKey="Collart M">MA Collart</name>
</author>
<author>
<name sortKey="Vassalli, P" uniqKey="Vassalli P">P Vassalli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shan, Y" uniqKey="Shan Y">Y Shan</name>
</author>
<author>
<name sortKey="Su, Y" uniqKey="Su Y">Y Su</name>
</author>
<author>
<name sortKey="Luo, X" uniqKey="Luo X">X Luo</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shenkar, R" uniqKey="Shenkar R">R Shenkar</name>
</author>
<author>
<name sortKey="Yum, Hk" uniqKey="Yum H">HK Yum</name>
</author>
<author>
<name sortKey="Arcaroli, J" uniqKey="Arcaroli J">J Arcaroli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shishodia, S" uniqKey="Shishodia S">S Shishodia</name>
</author>
<author>
<name sortKey="Aggarwal, Bb" uniqKey="Aggarwal B">BB Aggarwal</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shishodia, S" uniqKey="Shishodia S">S Shishodia</name>
</author>
<author>
<name sortKey="Potdar, P" uniqKey="Potdar P">P Potdar</name>
</author>
<author>
<name sortKey="Gairola, Cg" uniqKey="Gairola C">CG Gairola</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shishodia, S" uniqKey="Shishodia S">S Shishodia</name>
</author>
<author>
<name sortKey="Gutierrez, Am" uniqKey="Gutierrez A">AM Gutierrez</name>
</author>
<author>
<name sortKey="Lotan, R" uniqKey="Lotan R">R Lotan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Smith, Cj" uniqKey="Smith C">CJ Smith</name>
</author>
<author>
<name sortKey="Perfetti, Ta" uniqKey="Perfetti T">TA Perfetti</name>
</author>
<author>
<name sortKey="King, Ja" uniqKey="King J">JA King</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sopori, M" uniqKey="Sopori M">M Sopori</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sovak, Ma" uniqKey="Sovak M">MA Sovak</name>
</author>
<author>
<name sortKey="Bellas, Re" uniqKey="Bellas R">RE Bellas</name>
</author>
<author>
<name sortKey="Kim, Dw" uniqKey="Kim D">DW Kim</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tabakin Fix, Y" uniqKey="Tabakin Fix Y">Y Tabakin-Fix</name>
</author>
<author>
<name sortKey="Huleihel, M" uniqKey="Huleihel M">M Huleihel</name>
</author>
<author>
<name sortKey="Aboud, M" uniqKey="Aboud M">M Aboud</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tang, X" uniqKey="Tang X">X Tang</name>
</author>
<author>
<name sortKey="Liu, D" uniqKey="Liu D">D Liu</name>
</author>
<author>
<name sortKey="Shishodia, S" uniqKey="Shishodia S">S Shishodia</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tian, B" uniqKey="Tian B">B Tian</name>
</author>
<author>
<name sortKey="Zhang, Y" uniqKey="Zhang Y">Y Zhang</name>
</author>
<author>
<name sortKey="Luxon, Ba" uniqKey="Luxon B">BA Luxon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tsai, Sh" uniqKey="Tsai S">SH Tsai</name>
</author>
<author>
<name sortKey="Lin Shiau, Sy" uniqKey="Lin Shiau S">SY Lin-Shiau</name>
</author>
<author>
<name sortKey="Lin, Jk" uniqKey="Lin J">JK Lin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vanden Berghe, W" uniqKey="Vanden Berghe W">W Vanden Berghe</name>
</author>
<author>
<name sortKey="Plaisance, S" uniqKey="Plaisance S">S Plaisance</name>
</author>
<author>
<name sortKey="Boone, E" uniqKey="Boone E">E Boone</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Veale, D" uniqKey="Veale D">D Veale</name>
</author>
<author>
<name sortKey="Needham, G" uniqKey="Needham G">G Needham</name>
</author>
<author>
<name sortKey="Harris, Al" uniqKey="Harris A">AL Harris</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Venkataraman, L" uniqKey="Venkataraman L">L Venkataraman</name>
</author>
<author>
<name sortKey="Burakoff, Sj" uniqKey="Burakoff S">SJ Burakoff</name>
</author>
<author>
<name sortKey="Sen, R" uniqKey="Sen R">R Sen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vermeulen, L" uniqKey="Vermeulen L">L Vermeulen</name>
</author>
<author>
<name sortKey="De Wilde, G" uniqKey="De Wilde G">G De Wilde</name>
</author>
<author>
<name sortKey="Van Damme, P" uniqKey="Van Damme P">P Van Damme</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Voortman, J" uniqKey="Voortman J">J Voortman</name>
</author>
<author>
<name sortKey="Checinska, A" uniqKey="Checinska A">A Checinska</name>
</author>
<author>
<name sortKey="Giaccone, G" uniqKey="Giaccone G">G Giaccone</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, D" uniqKey="Wang D">D Wang</name>
</author>
<author>
<name sortKey="Baldwin, As" uniqKey="Baldwin A">AS Baldwin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, H" uniqKey="Wang H">H Wang</name>
</author>
<author>
<name sortKey="Cho, Ch" uniqKey="Cho C">CH Cho</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, J" uniqKey="Wang J">J Wang</name>
</author>
<author>
<name sortKey="Barke, Ra" uniqKey="Barke R">RA Barke</name>
</author>
<author>
<name sortKey="Charboneau, R" uniqKey="Charboneau R">R Charboneau</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="White, Es" uniqKey="White E">ES White</name>
</author>
<author>
<name sortKey="Flaherty, Kr" uniqKey="Flaherty K">KR Flaherty</name>
</author>
<author>
<name sortKey="Carskadon, S" uniqKey="Carskadon S">S Carskadon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Williams, Cs" uniqKey="Williams C">CS Williams</name>
</author>
<author>
<name sortKey="Mann, M" uniqKey="Mann M">M Mann</name>
</author>
<author>
<name sortKey="Dubois, Rn" uniqKey="Dubois R">RN DuBois</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wislez, M" uniqKey="Wislez M">M Wislez</name>
</author>
<author>
<name sortKey="Fujimoto, N" uniqKey="Fujimoto N">N Fujimoto</name>
</author>
<author>
<name sortKey="Izzo, Jg" uniqKey="Izzo J">JG Izzo</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wissink, S" uniqKey="Wissink S">S Wissink</name>
</author>
<author>
<name sortKey="Van Heerde, Ec" uniqKey="Van Heerde E">EC van Heerde</name>
</author>
<author>
<name sortKey="Schmitz, Ml" uniqKey="Schmitz M">ML Schmitz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Woronicz, Jd" uniqKey="Woronicz J">JD Woronicz</name>
</author>
<author>
<name sortKey="Gao, X" uniqKey="Gao X">X Gao</name>
</author>
<author>
<name sortKey="Cao, Z" uniqKey="Cao Z">Z Cao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Xiao, G" uniqKey="Xiao G">G Xiao</name>
</author>
<author>
<name sortKey="Harhaj, Ew" uniqKey="Harhaj E">EW Harhaj</name>
</author>
<author>
<name sortKey="Sun, Sc" uniqKey="Sun S">SC Sun</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Xiao, G" uniqKey="Xiao G">G Xiao</name>
</author>
<author>
<name sortKey="Fong, A" uniqKey="Fong A">A Fong</name>
</author>
<author>
<name sortKey="Sun, Sc" uniqKey="Sun S">SC Sun</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yamamoto, Y" uniqKey="Yamamoto Y">Y Yamamoto</name>
</author>
<author>
<name sortKey="Gaynor, Rb" uniqKey="Gaynor R">RB Gaynor</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yamaoka, S" uniqKey="Yamaoka S">S Yamaoka</name>
</author>
<author>
<name sortKey="Courtois, G" uniqKey="Courtois G">G Courtois</name>
</author>
<author>
<name sortKey="Bessia, C" uniqKey="Bessia C">C Bessia</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yang, Xd" uniqKey="Yang X">XD Yang</name>
</author>
<author>
<name sortKey="Huang, B" uniqKey="Huang B">B Huang</name>
</author>
<author>
<name sortKey="Li, M" uniqKey="Li M">M Li</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yang, Yt" uniqKey="Yang Y">YT Yang</name>
</author>
<author>
<name sortKey="Balch, C" uniqKey="Balch C">C Balch</name>
</author>
<author>
<name sortKey="Kulp, Sk" uniqKey="Kulp S">SK Kulp</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yao, H" uniqKey="Yao H">H Yao</name>
</author>
<author>
<name sortKey="Yang, Sr" uniqKey="Yang S">SR Yang</name>
</author>
<author>
<name sortKey="Kode, A" uniqKey="Kode A">A Kode</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yao, H" uniqKey="Yao H">H Yao</name>
</author>
<author>
<name sortKey="Edirisinghe, I" uniqKey="Edirisinghe I">I Edirisinghe</name>
</author>
<author>
<name sortKey="Yang, Sr" uniqKey="Yang S">SR Yang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yuan, A" uniqKey="Yuan A">A Yuan</name>
</author>
<author>
<name sortKey="Yang, Pc" uniqKey="Yang P">PC Yang</name>
</author>
<author>
<name sortKey="Yu, Cj" uniqKey="Yu C">CJ Yu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zandi, E" uniqKey="Zandi E">E Zandi</name>
</author>
<author>
<name sortKey="Rothwarf, Dm" uniqKey="Rothwarf D">DM Rothwarf</name>
</author>
<author>
<name sortKey="Delhase, M" uniqKey="Delhase M">M Delhase</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhang, Wj" uniqKey="Zhang W">WJ Zhang</name>
</author>
<author>
<name sortKey="Wei, H" uniqKey="Wei H">H Wei</name>
</author>
<author>
<name sortKey="Frei, B" uniqKey="Frei B">B Frei</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhong, H" uniqKey="Zhong H">H Zhong</name>
</author>
<author>
<name sortKey="Suyang, H" uniqKey="Suyang H">H SuYang</name>
</author>
<author>
<name sortKey="Erdjument Bromage, H" uniqKey="Erdjument Bromage H">H Erdjument-Bromage</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Arch Immunol Ther Exp (Warsz)</journal-id>
<journal-id journal-id-type="iso-abbrev">Arch. Immunol. Ther. Exp. (Warsz.)</journal-id>
<journal-title-group>
<journal-title>Archivum Immunologiae et Therapiae Experimentalis</journal-title>
</journal-title-group>
<issn pub-type="ppub">0004-069X</issn>
<issn pub-type="epub">1661-4917</issn>
<publisher>
<publisher-name>SP Birkhäuser Verlag Basel</publisher-name>
<publisher-loc>Basel</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">21786215</article-id>
<article-id pub-id-type="pmc">7079756</article-id>
<article-id pub-id-type="publisher-id">136</article-id>
<article-id pub-id-type="doi">10.1007/s00005-011-0136-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Batra</surname>
<given-names>Sanjay</given-names>
</name>
<address>
<email>sbatra@lsu.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Balamayooran</surname>
<given-names>Gayathriy</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahoo</surname>
<given-names>Malaya K.</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.64337.35</institution-id>
<institution-id institution-id-type="ISNI">0000000106627451</institution-id>
<institution>Department of Pathobiological Sciences, School of Veterinary Medicine,</institution>
<institution>Louisiana State University,</institution>
</institution-wrap>
Baton Rouge, LA 70803 USA</aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>7</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2011</year>
</pub-date>
<volume>59</volume>
<issue>5</issue>
<elocation-id>335</elocation-id>
<history>
<date date-type="received">
<day>7</day>
<month>1</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>3</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2011</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>NF-κB</kwd>
<kwd>Inflammation</kwd>
<kwd>Cancer</kwd>
<kwd>Lung</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2011</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p>Nuclear factor-κB (NF-κB) was first identified as a B-cell transcription factor protein that binds to the immunoglobulin heavy chain and the kappa light chain enhancers (Sen and Baltimore
<xref ref-type="bibr" rid="CR154">1986</xref>
,
<xref ref-type="bibr" rid="CR155">1987</xref>
). It is now known to comprise a family of ubiquitous proteins conserved from the fruit fly
<italic>Drosophila melanogaster</italic>
to humans. NF-κB controls the expression of more than 400 genes involved in a plethora of functions, such as immunoreceptor expression and expression of chemokines, cytokines, cell adhesion molecules, proliferation, transformation, apoptosis, angiogenesis, oxidative stress, invasion, and metastasis (Baeuerle and Henkel
<xref ref-type="bibr" rid="CR6">1994</xref>
; Giuliani et al.
<xref ref-type="bibr" rid="CR53">2001</xref>
; Kim et al.
<xref ref-type="bibr" rid="CR83">2006</xref>
; Lee and Burckart
<xref ref-type="bibr" rid="CR91">1998</xref>
). Extensive research has been carried out in the last few years to understand the role of NF-κB in inflammation and cancer in order to design strategies for blocking excessive NF-κB activity. This article focuses on NF-κB signaling pathways, emphasizing their role during pulmonary inflammation and cancer and their modulation with therapeutic agents.</p>
<p>Five mammalian NF-κB family members have been characterized and cloned. These are RelA (p65), RelB, c-Rel, NF-κB 1 (p50/p105), and NF-κB 2 (p52/p100) (Barkett and Gilmore
<xref ref-type="bibr" rid="CR10">1999</xref>
; Dutta et al.
<xref ref-type="bibr" rid="CR38">2006</xref>
; Ghosh et al.
<xref ref-type="bibr" rid="CR49">1998</xref>
; Hayden and Ghosh
<xref ref-type="bibr" rid="CR62">2004</xref>
; Jeong et al.
<xref ref-type="bibr" rid="CR72">2004</xref>
; Mercurio and Manning
<xref ref-type="bibr" rid="CR110">1999</xref>
; Nabel and Verma
<xref ref-type="bibr" rid="CR119">1993</xref>
; Pahl
<xref ref-type="bibr" rid="CR126">1999</xref>
; Shishodia and Aggarwal
<xref ref-type="bibr" rid="CR159">2004</xref>
). NF-κB family members share a highly conserved 300 amino acid Rel homology domain (RHD), responsible for their dimerization, binding to DNA and IκB (inhibitor of NF-κB) (Blank et al.
<xref ref-type="bibr" rid="CR13">1992</xref>
; Chen and Ghosh
<xref ref-type="bibr" rid="CR19">1999</xref>
; Gilmore
<xref ref-type="bibr" rid="CR50">1990</xref>
,
<xref ref-type="bibr" rid="CR51">2006</xref>
; Hayden and Ghosh
<xref ref-type="bibr" rid="CR62">2004</xref>
; Perkins and Gilmore
<xref ref-type="bibr" rid="CR130">2006</xref>
). The N-terminal part of the RHD contains the DNA-binding domain, whereas close to the C-terminal end of the RHD lies the nuclear localization sequence (NLS) which is essential for the transport of active NF-κB complexes into the nucleus. NF-κB proteins can be further subdivided into two groups: RelA, RelB and c-Rel which contain potent transactivation domains (TDs) within sequences C-terminal to the RHD are included in first group whereas, p50 and p52 which do not possess TDs and, therefore, cannot act as sole transcriptional activators comprise the second group. The TDs consist of abundant serine, acidic and hydrophobic amino acids which are essential for transactivation activity (Mercurio and Manning
<xref ref-type="bibr" rid="CR110">1999</xref>
; Perkins
<xref ref-type="bibr" rid="CR129">2007</xref>
; Wang and Baldwin
<xref ref-type="bibr" rid="CR174">1998</xref>
; Zhong et al.
<xref ref-type="bibr" rid="CR193">1997</xref>
).</p>
<p>The RHD of all Rel proteins (except Rel B) contains a phosphorylation site for PKA (25 aa N-terminal to the NLS). Phosphorylation of this site may be required for nuclear localization of the Rel proteins and/or may be involved in the transcriptional activity and DNA-binding (Scheinman et al.
<xref ref-type="bibr" rid="CR151">1995</xref>
; Wissink et al.
<xref ref-type="bibr" rid="CR180">1997</xref>
; Zhong et al.
<xref ref-type="bibr" rid="CR193">1997</xref>
). NF-κB is localized in cytoplasm associated with IκB inhibitory proteins in inactive form. Family members of IκB family include-IκBα, IκBβ, IκBγ (derived from the C-terminal of p100), IκBε, BCl-3, pp40 (a chicken homolog), cactus (a Drosophila homolog), and avian swine fever virus protein p28.2 (Baldwin
<xref ref-type="bibr" rid="CR8">1996</xref>
; Barkett and Gilmore
<xref ref-type="bibr" rid="CR10">1999</xref>
; Hatada et al.
<xref ref-type="bibr" rid="CR61">1992</xref>
; Hayden and Ghosh
<xref ref-type="bibr" rid="CR62">2004</xref>
). The balance of localization of NF-κB is dependent on IκBα degradation which leads to the exposure of masked NLS of p65 and also reduces the contribution of nuclear export sequence of IκBα (Arenzana-Seisdedos et al.
<xref ref-type="bibr" rid="CR4">1997</xref>
; Johnson et al.
<xref ref-type="bibr" rid="CR76">1999</xref>
). NF-κB functions only as a dimer, the most abundant activated dimeric form consists of a p50 or p52 subunit and a p65 subunit. However, NF-κB dimer composition depends on cell type, nature of stimulus or lag time after initial exposure to stimuli (Barkett and Gilmore
<xref ref-type="bibr" rid="CR10">1999</xref>
; Hayden and Ghosh
<xref ref-type="bibr" rid="CR62">2004</xref>
; Perkins
<xref ref-type="bibr" rid="CR127">1997</xref>
; Saccani et al.
<xref ref-type="bibr" rid="CR145">2003</xref>
). Homo- or heterodimers of p50 and p52 have been reported to repress κB site-dependent transcription in vivo (Lernbecher et al.
<xref ref-type="bibr" rid="CR93">1993</xref>
), possibly by competing with other transcriptionally active dimers (e.g., p50/RelA) for DNA binding. Interestingly, κB-site-dependent transcriptional activation by p50/p50 has been demonstrated in vitro (Lin et al.
<xref ref-type="bibr" rid="CR100">1995</xref>
).</p>
</sec>
<sec id="Sec2">
<title>NF-κB Signaling Pathways</title>
<sec id="Sec3">
<title>Classical Pathway</title>
<p>NF-κB signaling occurs through classical and non-classical pathways. In the classical pathway, tumor necrosis factor α (TNF-α) stimulation leads to activation/phosphorylation of IκB kinase (IKK) complex which then phosphorylates two N-terminal serine residues of IκB proteins. The IKK complex comprised IKKα, IKKβ and a regulatory subunit of IKKγ which is an NF-κB essential modulator (NEMO) (Mercurio et al.
<xref ref-type="bibr" rid="CR112">1999</xref>
; Rothwarf et al.
<xref ref-type="bibr" rid="CR144">1998</xref>
; Yamaoka et al.
<xref ref-type="bibr" rid="CR185">1998</xref>
). IKKα and IKKβ form homo or hetero dimers. Although IKKα and IKKβ cooperate for IκB phosphorylation, these kinases differ in the signal they mediate. IKKα and IKKβ have 52% amino acid homology with similar structural organization including kinase domain, leucine zipper and helix-loop-helix domains (Delhase et al.
<xref ref-type="bibr" rid="CR30">1999</xref>
; DiDonato et al.
<xref ref-type="bibr" rid="CR34">1997</xref>
; Li et al.
<xref ref-type="bibr" rid="CR95">1999</xref>
; Mercurio et al.
<xref ref-type="bibr" rid="CR111">1997</xref>
; Regnier et al.
<xref ref-type="bibr" rid="CR138">1997</xref>
; Woronicz et al.
<xref ref-type="bibr" rid="CR181">1997</xref>
; Zandi et al.
<xref ref-type="bibr" rid="CR191">1997</xref>
). MAP kinase domain of these proteins consists of closely spaced serine residues at positions 176 and 180 in IKKα and positions 177 and 181 in IKKβ. Phosphorylation of these serine residues by upstream kinases activates IKK kinase (DiDonato et al.
<xref ref-type="bibr" rid="CR34">1997</xref>
; Vanden Berghe et al.
<xref ref-type="bibr" rid="CR169">1998</xref>
; Zandi et al.
<xref ref-type="bibr" rid="CR191">1997</xref>
). Signals which induce NF-κB activity cause phosphorylation of IκB’s, subsequently leading to their dissociation and degradation thereby allowing NF-κB proteins to enter the nucleus and induce gene expression (Fig. 
<xref rid="Fig1" ref-type="fig">1</xref>
). The ubiquitination and subsequent degradation of IκB’s are mediated by the multicatalytic ATP-dependent 26S proteasome complex, the evidence for which was provided by the experiments with peptide aldehyde inhibitors of the proteasome, e.g., calpain inhibitor I (ALLN) (Karin and Ben-Neriah
<xref ref-type="bibr" rid="CR80">2000</xref>
).
<fig id="Fig1">
<label>Fig. 1</label>
<caption>
<p>Activation of NF-κB through different signaling pathways. The classical pathway of NF-κB activation involves TNF-α binds to TNFR1 and recruits the adaptors like TRAF2, TRADD and RIP to the membrane. These changes mediates the activation of IKK complex and subsequent phosphorylation of IκBα leading to its degradation. P65/p50 heterodimer is released and migrates to nucleus and activates target genes. The alternative pathway is triggered by DNA damage and is dependent on p38 and CK2 activation. Another alternate pathway of NF-κB activation is triggered by binding of CD40 ligand to its receptor. Recruitment of TRAF proteins leads to the activation of NIK and IKKα which causes processing of inhibitory protein p100 resulting in release of p52 which forms homodimers with RelB. Activation of NF-κB through TLR4 mediated pathway stimulated by LPS. Cigarette smoke activates NF-κB by inducing ROS production</p>
</caption>
<graphic xlink:href="5_2011_136_Fig1_HTML" id="MO1"></graphic>
</fig>
</p>
</sec>
<sec id="Sec4">
<title>Alternate Signaling Pathways of NF-κB</title>
<p>Besides the classical pathway, the alternate pathway is triggered by cytokines such as lymphotoxin, B-cell activating factor, CD40 ligand or viruses such as Epstein–Barr virus and T-cell leukemia virus. This pathway is NEMO independent and relies on the recruitment of TNF receptor associated factor (TRAF) proteins to the membrane and on NF-κB inducing kinase (NIK), which activates IKKα homodimer whose substrate is p100 (Xiao et al.
<xref ref-type="bibr" rid="CR182">2001</xref>
,
<xref ref-type="bibr" rid="CR183">2004</xref>
). Phosphorylated p100 undergoes ubiquitination and is cleaved to generate NF-κB protein p52 which moves to the nucleus as a heterodimer with RelB (Fig. 
<xref rid="Fig1" ref-type="fig">1</xref>
). The third pathway classified as atypical is independent of IKK but still requires proteasome and is triggered by DNA damage (Kato et al.
<xref ref-type="bibr" rid="CR81">2003</xref>
). UV radiation induces IκBα degradation via proteasome but the targeted serine residues are located within C-terminal cluster, which is recognized by p38 activated casein kinase 2 (Fig. 
<xref rid="Fig1" ref-type="fig">1</xref>
). Besides IκBα and p100, IκBβ is also targeted for phosphorylation at Ser19 and Ser23 by IKK complex which triggers its degradation. TNF-α and IKK phosphorylate p105 at Ser927 and Ser932 and lead to its ubiquitination and processing into p50. In addition, glycogen synthase kinase 3β phosphorylates p105 at Ser903 and Ser907 which primes on IKK-mediated phosphorylation of p105 and its subsequent degradation (Fig. 
<xref rid="Fig1" ref-type="fig">1</xref>
). Besides classical and alternate pathways for NF-κB activation, exposure of epithelial surface of lungs to cigarette smoke leads to increased NADPH oxidase derived reactive oxygen species (ROS) production which also plays a major role in the activation of NF-κB via NIK or MEKK/PKC-mediated pathways (Fig. 
<xref rid="Fig1" ref-type="fig">1</xref>
).</p>
</sec>
</sec>
<sec id="Sec5">
<title>NF-κB Activation</title>
<p>Activation of NF-κB is mediated through number of divergent stimuli. These include proinflammatory cytokines (e.g., TNF-α, interleukin (IL)-1, -2, -4, -8, -12, -15, -17 and -18), lipopolysaccharides (LPS), viral proteins, T- and B-cell mitogens, bacteria, viruses, double-stranded RNA, physical (asthma, hyperglycemia, acute lung injury, hemorrhage, proteinuria, biotin deficiency, etc.) and chemical stresses (including ionizing radiation, high fat diet, obesity, etc.), oxidative stress (superoxide ion, hydrogen peroxide, peroxynitrile radicals, nitric oxide (NO), etc.), environmental hazards including exposure to lead, extremes of pH, cigarette smoke, arsenic, silica particles, fatty acids, heat shock proteins (e.g., Hsp60), a number of chemotherapeutic agents, metals and physiological markers. Depending on the stimulus, the mechanism of NF-κB activation involves overlapping and non overlapping steps.</p>
<sec id="Sec6">
<title>Phosphorylation</title>
<p>Various kinases phosphorylate p65 in cytoplasm or in nucleus which is stimuli and/or cell type specific. Protein kinase A phosphorylates p65 at Serine276 during IκB degradation and is essential for the recruitment of CREB-binding protein/p300 to p65 for active transcription. Mitogens- and stress-activated protein kinase-1 also phosphorylate p65 at Serine276 following TNF stimulation (Vermeulen et al.
<xref ref-type="bibr" rid="CR172">2003</xref>
). In addition, protein kinase C-ζ-mediated phosphorylation at serine311 of p65 is required for the recruitment of CREB-binding protein and RNA polymerase II to the IL-6 promoter (Duran et al.
<xref ref-type="bibr" rid="CR37">2003</xref>
; Ikeda et al.
<xref ref-type="bibr" rid="CR68">2000</xref>
; McKay and Cidlowski
<xref ref-type="bibr" rid="CR107">2000</xref>
; Shenkar et al.
<xref ref-type="bibr" rid="CR158">2001</xref>
; Tabakin-Fix et al.
<xref ref-type="bibr" rid="CR165">2004</xref>
). The phosphorylation of Serine529 by casein kinase II and Serine536 by IκB kinases following TNF and LPS stimulation increases the transcriptional activity of NF-κB. Serine276 is within the RHD, which is involved in dimerization, whereas the Serines529 and 536 are in the C-terminal transactivation domain. Moreover, threonine phosphorylation of p65 at residue 254 has been shown to be required for Pin1 association and the increase in p65 stability. It is not known if these phosphorylations are mutually exclusive or whether all three are required for active transcription.</p>
<p>Recent studies have revealed that besides phosphorylation a multitude of other posttranslational modifications in this signaling system including acetylation, nitrosylation, ubiquitination, neddylation and sumoylation also play significant role in regulating the function of NF-κB (Mabb and Miyamoto
<xref ref-type="bibr" rid="CR104">2007</xref>
).</p>
</sec>
<sec id="Sec7">
<title>Acetylation</title>
<p>The crystal structure of the p50/p65 heterodimer bound to κB-DNA reveals that lysine 122 and 123 are the only residues that contact the DNA in the minor groove amongst p65 residues involved in DNA binding (Chen and Ghosh
<xref ref-type="bibr" rid="CR19">1999</xref>
). Although acetylation of other lysine residues of the p65 subunit which includes Lys218, Lys221 and Lys310 also plays a significant role in DNA-binding capacity (Chen et al.
<xref ref-type="bibr" rid="CR20">2002</xref>
) and transcriptional regulation of NF-κB. Acetylation of Lys122 and Lys123 within p65 has been shown to reduce NF-κB affinity to κB-DNA (Kiernan et al.
<xref ref-type="bibr" rid="CR82">2003</xref>
). Other studies have proposed that acetylation of p65 protects it from IκBα-mediated inhibition, however, histone deacetylase 3 (HDAC3)-mediated deacetylation of p65 renders it prone to IκBα-mediated interaction leading to its export from the nucleus (Glozak and Seto
<xref ref-type="bibr" rid="CR54">2007</xref>
).</p>
</sec>
<sec id="Sec8">
<title>Methylation</title>
<p>Inducible methylation and demethylation of p65 on residues Lys218 and Lys221 in response to IL-1β or TNF-α, or when NF-κB is constitutively activated, by the chromatin-remodeling enzymes FBXL11 and NSD1 have been reported earlier (Lu et al.
<xref ref-type="bibr" rid="CR103">2010</xref>
). These post-translational modifications profoundly affect the function of NF-κB. Interestingly, the same lysine residues can be methylated or acetylated, depending on the specific cellular context. The ways in which lysine methylation and acetylation are controlled to finely regulate NF-κB activity in normal and tumor cells, and the mechanisms that control the timing, location, intensity, residue specificity, and type of modification, are important issues for future research. This supports the notion that the differential posttranslational modifications of NF-κB which occur in response to different signals, such as phosphorylation, acetylation, and the methylation reported here, may specify different promoter-specific responses to activated NF-κB (Perkins
<xref ref-type="bibr" rid="CR128">2006</xref>
), leading to signal-specific downstream effects in response to different regulators, in different cell types, and in different specific contexts (Perkins and Gilmore
<xref ref-type="bibr" rid="CR130">2006</xref>
). It was demonstrated that Set9 methylates p65 at Lys37, Lys315 and Lys316 and regulates transcriptional activity of p65 (Ea and Baltimore
<xref ref-type="bibr" rid="CR39">2009</xref>
; Yang et al.
<xref ref-type="bibr" rid="CR186">2009a</xref>
). Methylated p65 localizes in nucleus and regulates the stability of DNA-p65 complexes thereby affecting the recruitment of p65 to the promoter. The differences in in vitro findings from different groups have been attributed to the use of different epitope tags in generating recombinant p65 fragments.</p>
</sec>
</sec>
<sec id="Sec9">
<title>Lung Inflammation</title>
<p>NF-κB is a critical transcription factor for host immune mechanisms both in innate and adaptive responses. Activation of NF-κB transcription factors upregulates number of proinflammatory proteins, such as cytokines, chemokines, cell adhesion molecules and proteases which help to recruit leukocytes and degrade the bacteria. Chemokines and adhesion molecules serve to recruit and activate immune cells such as neutrophils, eosinophils, macrophages, and lymphocytes (Poynter et al.
<xref ref-type="bibr" rid="CR135">2002</xref>
) to the site of inflammation. NF-κB regulated proteins include eotaxin (Hein et al.
<xref ref-type="bibr" rid="CR64">1997</xref>
), IL-6 (Sanceau et al.
<xref ref-type="bibr" rid="CR147">1995</xref>
), IL-8 (Harant et al.
<xref ref-type="bibr" rid="CR59">1996</xref>
), macrophage-inflammatory protein-2 (MIP-2) (Driscoll et al.
<xref ref-type="bibr" rid="CR35">1995</xref>
), granulocyte–macrophage colony-stimulating factor (Dunn et al.
<xref ref-type="bibr" rid="CR36">1994</xref>
), inducible NO synthase (Kleinert et al.
<xref ref-type="bibr" rid="CR84">1996</xref>
), intercellular adhesion molecule 1 (ICAM-1) (Roebuck et al.
<xref ref-type="bibr" rid="CR143">1995</xref>
), cyclooxygenase-2 (Schmedtje et al.
<xref ref-type="bibr" rid="CR153">1997</xref>
), and TNF-α (Collart et al.
<xref ref-type="bibr" rid="CR24">1990</xref>
; Shakhov et al.
<xref ref-type="bibr" rid="CR156">1990</xref>
). Respiratory tract infection has remained a leading cause of death worldwide among all the infectious diseases (Mizgerd
<xref ref-type="bibr" rid="CR115">2008</xref>
). Pneumonia is an important concern worldwide as it causes mortality in adults and in children. Pneumonia can be caused by a variety of microbes, such as bacteria, viruses and fungi. Bacteria or virus induce a variety of genes, most of them are regulated by the κB sites in the DNA which bind to NF-κB transcription factors subsequent to pulmonary infection (Balamayooran et al.
<xref ref-type="bibr" rid="CR7">2010</xref>
).</p>
<sec id="Sec10">
<title>Bacterial Infection</title>
<sec id="Sec11">
<title>Toll-Like Receptor-Mediated Activation of NF-κB</title>
<p>NF-κB activation via Toll-like receptor 4 (TLR4)-mediated signaling plays an important role during
<italic>Haemophilus pneumoniae</italic>
infection (Lim et al.
<xref ref-type="bibr" rid="CR99">2008</xref>
), whereas MD-2, a key molecule in TLR4-mediated signaling is shown to regulate NF-κB activation during pulmonary
<italic>Escherichia coli</italic>
infection (Cai et al.
<xref ref-type="bibr" rid="CR17">2009b</xref>
). Protection of mice by endogenous NF-κB during
<italic>E. coli</italic>
(Alcamo et al.
<xref ref-type="bibr" rid="CR1">2001</xref>
; Mizgerd et al.
<xref ref-type="bibr" rid="CR116">2003</xref>
) and pneumococcal pneumonia has been reported earlier (Quinton et al.
<xref ref-type="bibr" rid="CR137">2007</xref>
). TIRAP also plays an essential role in the NF-κB regulation during
<italic>E. coli</italic>
infection (Jeyaseelan et al.
<xref ref-type="bibr" rid="CR73">2005</xref>
). Similarly, TRIF is important for the TLR3 and TLR4-mediated signaling and is essential for late NF-κB activation during pulmonary
<italic>E. coli</italic>
(Jeyaseelan et al.
<xref ref-type="bibr" rid="CR75">2007</xref>
)
<italic>, Pseudomonas aeruginosa</italic>
(Power et al.
<xref ref-type="bibr" rid="CR134">2007</xref>
) and
<italic>Klbesiella pneumoniae</italic>
infection (Cai et al.
<xref ref-type="bibr" rid="CR16">2009a</xref>
) (Fig. 
<xref rid="Fig2" ref-type="fig">2</xref>
). LPS-induced expression of chemokines KC and MIP-2 is not significantly affected by TNFR1 deficiency, however, expression of both the chemokines is almost entirely inhibited by combined deficiency of TNFR1 and RelA. The LPS-induced increase in pulmonary ICAM-1 expression has been shown to be reduced by the deficiency of TNFR1 alone and more prominently by TNFR1 and RelA combined deficiency (Jones et al.
<xref ref-type="bibr" rid="CR77">2005</xref>
). These observations reveal that RelA isoform of NF-κB promotes the coordinated expression of cell adhesion molecules and chemokines essential to neutrophil immigration in response to bacterial LPS in the lungs (Sawa et al.
<xref ref-type="bibr" rid="CR149">2008</xref>
; Shan et al.
<xref ref-type="bibr" rid="CR157">2002</xref>
). An in vitro study showed that
<italic>Legionella pneumophila</italic>
induced the degradation of IκBα and activated NF-κB. Inhibition of IKK blocked
<italic>L. pneumophila-</italic>
induced prostaglandin E(2) release and COX-2 expression via NF-κB and TNF-α pathway and thus significantly contribute to the host response in Legionnaire’s disease (N’Guessan et al.
<xref ref-type="bibr" rid="CR122">2007</xref>
). A study with macrophages from p47
<sup>phox−/−</sup>
(a component of NADPH oxidase complex) mice confirmed that redox signaling was necessary for maximal TLR4-dependent NF-κB activation during
<italic>P. aeruginosa</italic>
infection (Sadikot et al.
<xref ref-type="bibr" rid="CR146">2004</xref>
).
<fig id="Fig2">
<label>Fig. 2</label>
<caption>
<p>Respiratory pathogens activate complex signaling pathways via Toll-like receptors (TLR) and Nod-like receptors leading to the activation of NF-κB</p>
</caption>
<graphic xlink:href="5_2011_136_Fig2_HTML" id="MO2"></graphic>
</fig>
</p>
</sec>
<sec id="Sec12">
<title>NLR-Mediated Activation of NF-κB</title>
<p>In vitro experiments have demonstrated that NF-κB activation by
<italic>Streptococcus pneumoniae</italic>
is dependent on NOD2 and mediated by protein kinases IRAKs (IL-1 receptor activated kinase). NOD2 also senses intracellular
<italic>S. pneumoniae</italic>
in macrophages upon phagocytosis and induces cytokine production via NF-κB pathway (Opitz et al.
<xref ref-type="bibr" rid="CR125">2004</xref>
). In a recent study with combined deficiency of TNF-α and IL-1 signaling, reduced NF-κB activation and chemokines expression were observed during pulmonary infection by
<italic>S. pneumoniae</italic>
compared to
<italic>E. coli</italic>
showing the importance of TNF-α and IL-1 (Quinton et al.
<xref ref-type="bibr" rid="CR137">2007</xref>
). Using heat-killed
<italic>Staphylococcus</italic>
<italic>aureus</italic>
Kapetanovic et al. (
<xref ref-type="bibr" rid="CR79">2007</xref>
) showed that NOD1 and NOD2-mediated signaling is important for cytokine production via NF-κB activation (Fig. 
<xref rid="Fig2" ref-type="fig">2</xref>
).</p>
<p>These observations reveal that both extracellular and intra-cellular pattern recognition receptors regulate NF-κB through MyD88-dependent and independent pathways triggered by variety of pathogens.</p>
</sec>
<sec id="Sec13">
<title>Cell-Specific Responses of NF-κB Signaling</title>
<p>Regarding cell specific response, it is important to discuss the role of both hematopoetic and non-hematopoietic cells. Neutrophils purified from bone marrow cells and bone marrow-derived macrophages (BMMs) from CXCL2 and CCR2 gene deficient mice were unable to activate NF-κB signaling subsequent to pulmonary infection with gram negative bacteria. MD-2 has been shown to be expressed in both these cell types and is important for neutrophil-mediated inflammation. MD-2 regulates NF-κB driven TNF-α, MIP-2, and IL-6 in the lungs following LPS challenge (Cai et al.
<xref ref-type="bibr" rid="CR17">2009b</xref>
). BMMs modulate lung inflammation upon
<italic>K. pneumoniae</italic>
infection via ELR
<sup>+</sup>
CXC chemokine KC-mediated activation of NF-κB and MAPKs (Cai et al.
<xref ref-type="bibr" rid="CR18">2010</xref>
). In addition, signals from both hematopoetic and non-hematopoietic cells are essential to control
<italic>P. aeruginosa</italic>
replication. During initial phase of infection, MyD88 expression in resident cells plays a vital role in chemokine production and controlling infection whereas early TNF-α and IL-1β production was also dependent on MyD88 signaling in bone marrow cells (Hajjar et al.
<xref ref-type="bibr" rid="CR57">2005</xref>
). Another study with RelA deficient airway epithelial cells resulted in observations leading to decreased cytokine expression, alveolar neutrophil influx, and lung bacterial killing during
<italic>S. pneumoniae</italic>
infection (Schmeck et al.
<xref ref-type="bibr" rid="CR152">2004</xref>
). Furthermore, mice expressing a dominant-negative form of IκBα in airway epithelial cells also showed impaired bacterial killing in the lungs implicating importance of NF-κB activation during pneumonia. Using transgenic mice expressing mutated IκBα (IκBα
<sub>SR</sub>
) exclusively in airway epithelial cells which acts as repressor of NF-κB, Poynter et al. (
<xref ref-type="bibr" rid="CR136">2003</xref>
) demonstrated the role of airway epithelial cells in regulating secretion of cytokines/chemokines during intranasal administration of LPS. Koay et al. (
<xref ref-type="bibr" rid="CR86">2002</xref>
) used liposome-encapsulated clodronate to deplete macrophages and study the role of macrophages in the pathogenesis of neutrophilic lung inflammation in response to intraperitoneal (i.p.) LPS. The observations from this study revealed the involvement of both pulmonary and extrapulmonary macrophage pool in controlling LPS-induced pulmonary inflammation. Intra tracheal administration of clodronate (for macrophage depletion) resulted in reduced NF-κB-binding activity, cytokines/chemokines production and ICAM-1 expression. Together, these findings conclusively reveal the importance of NF-κB-mediated signaling in both hematopoetic and non-hematopoietic cells (Lentsch et al.
<xref ref-type="bibr" rid="CR92">1999</xref>
). Comprehensive mechanisms that involve in NF-κB activation by different bacterial species are shown in Fig. 
<xref rid="Fig2" ref-type="fig">2</xref>
and Table 
<xref rid="Tab1" ref-type="table">1</xref>
.
<table-wrap id="Tab1">
<label>Table 1</label>
<caption>
<p>Regulation of NF-κB during bacterial and viral infection of lungs</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">NF-κB subunit</th>
<th align="left">Infection</th>
<th align="left">Regulators</th>
<th align="left">Host immune defense</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">p50</td>
<td align="left">
<italic>Escherichia coli</italic>
(Mizgerd et al.
<xref ref-type="bibr" rid="CR116">2003</xref>
)</td>
<td align="left"></td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">RelA</td>
<td align="left">
<italic>Streptococcus pneumoniae</italic>
(Alcamo et al.
<xref ref-type="bibr" rid="CR1">2001</xref>
)</td>
<td align="left"></td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">p50/RelA (NF-κB)</td>
<td align="left">
<italic>Escherichia coli</italic>
(Cai et al.
<xref ref-type="bibr" rid="CR17">2009b</xref>
; Jeyaseelan et al.
<xref ref-type="bibr" rid="CR73">2005</xref>
; Jeyaseelan et al.
<xref ref-type="bibr" rid="CR75">2007</xref>
)</td>
<td align="left">TLR4, MD-2, TRIF, TIRAP</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">p50/RelA (NF-κB)</td>
<td align="left">
<italic>Streptococcus</italic>
<italic>pneumoniae</italic>
(Alcamo et al.
<xref ref-type="bibr" rid="CR1">2001</xref>
; Opitz et al.
<xref ref-type="bibr" rid="CR125">2004</xref>
; Quinton et al.
<xref ref-type="bibr" rid="CR137">2007</xref>
; Schmeck et al.
<xref ref-type="bibr" rid="CR152">2004</xref>
; Wang et al.
<xref ref-type="bibr" rid="CR176">2008</xref>
)</td>
<td align="left">TLR9, NOD1, NOD2, TNF-α, IL-1</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">p50/RelA (NF-κB)</td>
<td align="left">
<italic>Haemophilus pneumoniae</italic>
(Frantz et al.
<xref ref-type="bibr" rid="CR47">1994</xref>
).</td>
<td align="left">TLR4</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">p50/RelA (NF-κB)</td>
<td align="left">
<italic>Pseudomonas aeruginosa</italic>
(Jeyaseelan et al.
<xref ref-type="bibr" rid="CR74">2006</xref>
; Power et al.
<xref ref-type="bibr" rid="CR134">2007</xref>
; Sadikot et al.
<xref ref-type="bibr" rid="CR146">2004</xref>
)</td>
<td align="left">TLR4, TRIF, p47
<sup>phox</sup>
</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">p50/RelA (NF-κB)</td>
<td align="left">
<italic>Klbesiella pneumoniae</italic>
(Jeyaseelan et al.
<xref ref-type="bibr" rid="CR74">2006</xref>
)</td>
<td align="left">TRIF</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">p50/RelA (NF-κB)</td>
<td align="left">
<italic>Streptococcus</italic>
<italic>pneumoniae</italic>
(Wang et al.
<xref ref-type="bibr" rid="CR176">2008</xref>
)</td>
<td align="left">Morphine (exogenous)</td>
<td align="left">↓</td>
</tr>
<tr>
<td align="left">p50/RelA (NF-κB)</td>
<td align="left">RSV (Tian et al.
<xref ref-type="bibr" rid="CR167">2002</xref>
)</td>
<td align="left">IκB</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">NF-κB</td>
<td align="left">Influenza virus (Nimmerjahn et al.
<xref ref-type="bibr" rid="CR123">2004</xref>
)</td>
<td align="left">(active NFκB promote influenza virus)</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">p50</td>
<td align="left">Gamma herpes virus (Krug et al.
<xref ref-type="bibr" rid="CR87">2010</xref>
)</td>
<td align="left">(p50 is required for virus reactivation)</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">NF-κB</td>
<td align="left">Rhino virus (Hewson et al.
<xref ref-type="bibr" rid="CR66">2010</xref>
)</td>
<td align="left">MAPK</td>
<td align="left">↑</td>
</tr>
<tr>
<td align="left">NF-κB</td>
<td align="left">SARS virus (Corona virus) (Fang et al.
<xref ref-type="bibr" rid="CR45">2007</xref>
)</td>
<td align="left">IKKβ</td>
<td align="left">↓</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>
<italic>TIRAP</italic>
Toll/IL-1R domain-containing adaptor protein,
<italic>TRIF</italic>
Toll/IL-1 receptor domain-containing adaptor inducing IFN-β</p>
</table-wrap-foot>
</table-wrap>
</p>
</sec>
</sec>
<sec id="Sec14">
<title>Viral Infection</title>
<p>Respiratory syncitial virus (RSV) is a ubiquitous human respiratory tract pathogen known to produce severe lower respiratory tract infections. During RSV infection, NF-κB has shown to regulate the expression of an array of proteins such as chemokines, transcriptional regulators, intracellular proteins regulating translation and proteolysis, and secreted proteins (complement components and growth factor regulators) (Tian et al.
<xref ref-type="bibr" rid="CR167">2002</xref>
). Furthermore, NF-κB activation is a prerequisite for influenza viral infection. It has been shown that cells with low NF-κB activity were resistant to influenza viral infection and they become susceptible upon activation of NF-κB. Primary human cells and lung cancer cell lines (A549 and U1752) were used in this study to elucidate that blocking of NF-κB significantly impaired influenza viral infection in these cells. This group also showed that vaccinia virus infection in these cells was independent of NF-κB activation demonstrating the specificity of NF-κB pathway (Nimmerjahn et al.
<xref ref-type="bibr" rid="CR123">2004</xref>
). Interestingly, severe acute respiratory syndrome coronavirus (SARS-CoV) M suppresses NF-κB activity through a direct interaction with IKKβ, resulting in lower COX-2 expression and SARS pathogenesis (Fang et al.
<xref ref-type="bibr" rid="CR45">2007</xref>
). Idiopathic pulmonary fibrosis is a chronic progressive lung disorder of unknown etiology which is associated with a gamma herpesviral infection. Studies have also shown that inhibition of NF-κB reduces viral load and ameliorates profibrotic events (Krug et al.
<xref ref-type="bibr" rid="CR87">2010</xref>
). In addition during rhino viral infection in humans, MUC5AC a major mucin produced by bronchial epithelial cells is induced via NF-κB pathway (Hewson et al.
<xref ref-type="bibr" rid="CR66">2010</xref>
) (Table 
<xref rid="Tab1" ref-type="table">1</xref>
).</p>
<p>Considering these pivotal roles of NF-κB during viral infections, it is increasingly becoming an important therapeutic target molecule.</p>
<sec id="Sec15">
<title>Cigarette Smoke-Induced Inflammation</title>
<p>Cigarette smoke (CS) is a potent stimulus of inflammation in the lungs as it contains more than over 4,000 different compounds (Burns
<xref ref-type="bibr" rid="CR15">1991</xref>
). Bioactive LPS is one of the major components in the CS that may contribute to the pathogenesis (Hasday et al.
<xref ref-type="bibr" rid="CR60">1999</xref>
). CS is the main etiological factor in the pathogenesis of chronic obstructive pulmonary disease (COPD), causing oxidative stress, a key feature in smoking induced lung inflammation. CS provokes severe inflammation that results in the NF-κB-dependent production of cytokines, such as TNF-α and IL-6, and the recruitment of neutrophils to the lungs leading to acute lung injury or emphysema (Churg et al.
<xref ref-type="bibr" rid="CR23">2002</xref>
; Deng et al.
<xref ref-type="bibr" rid="CR31">2002</xref>
; MacNee et al.
<xref ref-type="bibr" rid="CR105">1989</xref>
). Studies have also shown that CS not only induces inflammation in the lungs but also reduces the pulmonary host defence and make the respiratory system more prone to infections. Smokers incur twofold to fourfold increased risk to invasive pneumococcal disease and increased risk of influenza and tuberculosis infections (Arcavi and Benowitz
<xref ref-type="bibr" rid="CR3">2004</xref>
). It has been reported earlier that bacterial burden in CS-exposed mice was increased 24 and 48 h post-infection and this was accompanied by a more pronounced clinical appearance of illness, hypothermia, and increased lung homogenate cytokines IL-1β, IL-6, IL-10, and TNF-α (Phipps et al.
<xref ref-type="bibr" rid="CR131">2010</xref>
). Interestingly, another group has found that CS changes the bacterial colony in the oral cavity to gram negative bacilli and thus potentiate the chances of aspiration pneumonia caused by gram negative bacteria (Ertel et al.
<xref ref-type="bibr" rid="CR43">1991</xref>
).</p>
<p>Using NF-κB-decoy oligodeoxynucleotides on long-term CS-induced lung inflammation and pathology in mice, it has been shown that NF-κB plays an important role in the recruitment of macrophages and pulmonary dysfunction in smoke-induced chronic lung inflammation (Li et al.
<xref ref-type="bibr" rid="CR96">2009</xref>
). CS extract activates NF-κB and up-regulates Bcl-XL in human bronchial epithelial cells, and p65 deficiency in the cells leads to CS-mediated cell death suggesting that activation of NF-κB regulates cell survival following DNA damage by CS (Liu et al.
<xref ref-type="bibr" rid="CR101">2008</xref>
).</p>
</sec>
<sec id="Sec16">
<title>CS-Mediated ROS Production and NF-κB Activation</title>
<p>NADPH oxidase-derived ROS production upon the exposure of epithelial surface of lungs to CS also plays a major role in the activation of NF-κB (Yao et al.
<xref ref-type="bibr" rid="CR188">2007</xref>
) (Fig. 
<xref rid="Fig1" ref-type="fig">1</xref>
). Studies have shown that LPS and
<italic>P. aeruginosa</italic>
-induced lung NF-κB activation was impaired in knockout mice for NADPH oxidase member proteins such as p47
<sup>phox</sup>
and gp91
<sup>phox</sup>
(Koay et al.
<xref ref-type="bibr" rid="CR85">2001</xref>
). Sadikot et al. (
<xref ref-type="bibr" rid="CR146">2004</xref>
) have demonstrated that the activation of RelA subunit of NF-κB was decreased in the lungs of p47
<sup>phox−/−</sup>
and gp91
<sup>phox−/−</sup>
mice compared with wild-type (WT) mice in response to CS exposure. In contrast, other report demonstrated that NADPH deficiency enhances LPS-induced acute inflammatory responses in vivo (Zhang et al.
<xref ref-type="bibr" rid="CR192">2009</xref>
). Furthermore, a low i.p. dose of LPS [5 μg/g body weight (bw)], equally induced pulmonary NF-κB activation in p47
<sup>phox−/−</sup>
and WT mice, however, 20 μg/g bw, i.p. dose of LPS-mediated NF-κB activation was lower in p47
<sup>phox−/−</sup>
mice (Koay et al.
<xref ref-type="bibr" rid="CR85">2001</xref>
). In support of these observations, another report showed that susceptibility to cigarette smoke-induced lung inflammation and emphysema was significantly enhanced in mice genetically ablated of NADPH oxidase (p47
<sup>phox</sup>
and gp91
<sup>phox</sup>
) (Yao et al.
<xref ref-type="bibr" rid="CR189">2008</xref>
). These contradictory findings clearly state that low dose of LPS does not induce NF-κB activation via ROS, or that mice deficient in NADPH oxidase components can compensate this defect by either xanthine oxidase (Faggioni et al.
<xref ref-type="bibr" rid="CR44">1994</xref>
; Nakai et al.
<xref ref-type="bibr" rid="CR120">2006</xref>
) or mitochondria-mediated ROS production (Boczkowski et al.
<xref ref-type="bibr" rid="CR14">1999</xref>
; Ritter et al.
<xref ref-type="bibr" rid="CR141">2003</xref>
). Interestingly, variations in LPS doses, difference in observation times and use of different animal models may also play an important role in differential regulation of NF-κB.</p>
</sec>
<sec id="Sec17">
<title>CS-Mediated HDAC Regulation and NF-κB Activation</title>
<p>The other key players to regulate transcriptional activity of NF-κB are histone deacetylases (HDACs). HDACs play an important role in maintaining the balance of histone acetylation/deacetylation and/or transcriptional activity of pro-inflammatory genes in cells by the removal of acetyl groups from lysine residues at the N-terminal ends of core histone and also of non-histone proteins. CS-mediated reduction in HDAC2 has been associated with increased RelA activation (Yao et al.
<xref ref-type="bibr" rid="CR188">2007</xref>
). It has also been observed that RelA interacts with HDAC2 and becomes available or retained in the nucleus for pro-inflammatory gene transcription when HDAC2 is decreased (Yang et al.
<xref ref-type="bibr" rid="CR187">2009b</xref>
). Therefore, understanding the mechanism of regulation of HDAC2 could provide scope for therapeutic modulation of steroid resistance in CS-induced lung inflammation.</p>
<p>CS causes immunosuppression in smokers because most of the constituents in CS are toxic to the cells. These components break the innate immune barriers in the respiratory system, thereby making it vulnerable to infections. Some components like LPS stimulate innate immune cells such as alveolar macrophages and epithelial cells to produce pro-inflammatory mediators such as chemokines and cytokine. Furthermore, constitutive CS exposure causes progressive damage to innate immune barrier thereby stimulating inflammation. Therefore, chronic CS exposure makes the vicious cycle to go on. This is the reason why although CS is immunosuppressive at the same time inflammatory (Mehta et al.
<xref ref-type="bibr" rid="CR108">2008</xref>
; Sopori
<xref ref-type="bibr" rid="CR163">2002</xref>
). However, investigations to elucidate the related molecular mechanisms are still warranted.</p>
</sec>
</sec>
</sec>
<sec id="Sec18">
<title>Role of NF-κB in Lung Cancer</title>
<p>More than one million people worldwide die from lung cancer each year, which is the leading cause of cancer mortality worldwide. Intimate association exists between chronic inflammation and promotion of cancer as evidenced by tumor infiltration of immune cells with poor clinical outcome (Coussens and Werb
<xref ref-type="bibr" rid="CR26">2002</xref>
).</p>
<sec id="Sec19">
<title>Bronchogenic Carcinomas</title>
<p>Lung cancers, also known as bronchogenic carcinomas, are broadly classified into two types: small cell lung cancers (SCLC) and non-small cell lung cancers (NSCLC). SCLC comprises about 20% of lung cancers and is the most aggressive and rapidly growing of all lung cancers. NSCLC are the most common lung cancers, accounting for about 80% of all lung cancers (Meylan et al.
<xref ref-type="bibr" rid="CR114">2009</xref>
). Immunohistochemically higher expression of nuclear of NF-κB/p65 was observed in SCLCs as compared with NSCLCs (Tang et al.
<xref ref-type="bibr" rid="CR166">2006</xref>
). Peroxisome proliferator-activated receptor-βδ agonist induced proliferation of NSCLC cells by inhibiting the expression of phosphate and tensin homolog deleted on chromosome 10 (PTEN) which stimulates PI3K/Akt and NF-κB signaling (Han et al.
<xref ref-type="bibr" rid="CR58">2008</xref>
) (Table 
<xref rid="Tab2" ref-type="table">2</xref>
). Targeting the NF-κB signaling pathway may also help sensitize cancer cells to TNF-related apoptosis-inducing ligand (TRAIL, also known as Apo2L). Using a complementary gene therapy modality, it was demonstrated that combination treatment with Ad5hTRAIL and AdIKKβKA induced significant apoptosis of TRAIL-resistant A549 cells, suggesting that dual gene therapy strategy involving exogenous TRAIL gene expression with concurrent IKK inhibition may be a promising gene therapy modality to treat lung cancer (Aydin et al.
<xref ref-type="bibr" rid="CR5">2010</xref>
).
<table-wrap id="Tab2">
<label>Table 2</label>
<caption>
<p>Regulation of NF-κB during lung cancer by endogenous and exogenous agents</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left"></th>
<th align="left">NF-κB regulation</th>
<th align="left">Probability of tumorigenisis</th>
<th align="left">Type</th>
<th align="left">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="5">Endogenous regulators</td>
</tr>
<tr>
<td align="left"> p53</td>
<td align="left">↑</td>
<td align="left">↑</td>
<td align="left">NSCLC</td>
<td align="left">Rodin and Rodin
<xref ref-type="bibr" rid="CR142">2000</xref>
</td>
</tr>
<tr>
<td align="left"> K-Ras (oncogenic Ras)</td>
<td align="left">↑</td>
<td align="left">↑</td>
<td align="left">Lung adenocarcinoma</td>
<td align="left">Meylan et al.
<xref ref-type="bibr" rid="CR114">2009</xref>
; Tang et al.
<xref ref-type="bibr" rid="CR166">2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="5">Exogenous regulators</td>
</tr>
<tr>
<td align="left"> CS</td>
<td align="left">↑</td>
<td align="left">↑</td>
<td align="left">Lung carcinoma</td>
<td align="left">Liu et al.
<xref ref-type="bibr" rid="CR101">2008</xref>
; Tang et al.
<xref ref-type="bibr" rid="CR166">2006</xref>
</td>
</tr>
<tr>
<td align="left"> Benzopyrene in CS</td>
<td align="left">↑</td>
<td align="left">↑</td>
<td align="left">Lung carcinoma</td>
<td align="left">Shishodia et al.
<xref ref-type="bibr" rid="CR160">2003</xref>
</td>
</tr>
<tr>
<td align="left"> PPARβ/δ agonist</td>
<td align="left">↑</td>
<td align="left">↑</td>
<td align="left">NSCLC</td>
<td align="left">Han et al.
<xref ref-type="bibr" rid="CR58">2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="5">Exogenous regulators/treatment options</td>
</tr>
<tr>
<td align="left"> Pyrrolidine dithiocarbonate</td>
<td align="left">↓</td>
<td align="left"></td>
<td align="left"></td>
<td align="left">Frode-Saleh and Calixto
<xref ref-type="bibr" rid="CR48">2000</xref>
</td>
</tr>
<tr>
<td align="left"> Calpain-1 inhibitor</td>
<td align="left">↓</td>
<td align="left"></td>
<td align="left"></td>
<td align="left">Lancaster et al.
<xref ref-type="bibr" rid="CR89">2001</xref>
</td>
</tr>
<tr>
<td align="left"> SiRNA</td>
<td align="left">↓</td>
<td align="left"></td>
<td align="left"></td>
<td align="left">Chen et al.
<xref ref-type="bibr" rid="CR21">2008</xref>
</td>
</tr>
<tr>
<td align="left"> Bortezomib</td>
<td align="left">↓</td>
<td align="left"></td>
<td align="left"></td>
<td align="left">Denlinger et al.
<xref ref-type="bibr" rid="CR32">2004</xref>
; Mortenson et al.
<xref ref-type="bibr" rid="CR117">2004</xref>
</td>
</tr>
<tr>
<td align="left"> Farnesol like agents</td>
<td align="left">↑</td>
<td align="left"></td>
<td align="left"></td>
<td align="left">Joo and Jetten
<xref ref-type="bibr" rid="CR78">2010</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>
<italic>PPARβ/δ</italic>
peroxisome proliferator-activated receptor-βδ,
<italic>CS</italic>
cigarette smoke,
<italic>NSCLC</italic>
non-small cell lung cancers</p>
</table-wrap-foot>
</table-wrap>
</p>
</sec>
<sec id="Sec20">
<title>CS and Bronchogenic Carcinomas</title>
<p>Environmental factors such as tobacco smoke and genetic susceptibility interact to influence carcinogenesis. The gas phase of CS contains free radicals such as superoxide radicals, hydroxyl radicals and hydrogen peroxide, which potentially can activate NF-κB (Shishodia et al.
<xref ref-type="bibr" rid="CR160">2003</xref>
). Benzopyrene, another potent carcinogen of CS, can also activate NF-κB, but by an unknown mechanism (Shishodia et al.
<xref ref-type="bibr" rid="CR160">2003</xref>
) (Table 
<xref rid="Tab2" ref-type="table">2</xref>
). NF-κB activation plays an important role in lung cancer pathogenesis and is a suitable target for the development of new lung cancer therapies and chemoprevention strategies (Meylan et al.
<xref ref-type="bibr" rid="CR114">2009</xref>
). It has been shown that nuclear RelA and IκBα are potential markers of NSCLC and associated with poor prognosis. In addition, CS can induce DNA damage and cell cycle arrest without leading to apoptosis, but also stimulates NF-κB-DNA binding activity and up-regulates Bcl-XL (Liu et al.
<xref ref-type="bibr" rid="CR101">2008</xref>
). This group suggested that by damaging the DNA and inhibiting apoptosis through NF-κB, CS can cause epigenetic changes and/or somatic cell mutations that can lead to lung cancer.</p>
</sec>
<sec id="Sec21">
<title>Inflammation and Cancer</title>
<p>Recurrent or chronic inflammation may induce or increase the susceptibility to tumorigenesis by damaging the DNA, eliciting reparative proliferation and creating a stromal tissue enriched with inflammatory and growth signal molecules. Persistent inflammation causes constitutive stress to the tissue and modifies its growth signal leading to metaplastic tissue which will eventually become neoplastic (Coussens and Werb
<xref ref-type="bibr" rid="CR26">2002</xref>
). Chronic inflammation may involve unresolved acute inflammation or evolve over a period of time without a clinical manifestation of acute inflammation. Chronic inflammation is characterized by cellular influx predominantly with macrophages and lymphocytes, multiple permeable small blood vessels, fibrosis and necrosis. Activated macrophages and lymphocytes produce cytokines and chemokines which further amplify the inflammatory signal will result in concurrent tissue destruction and repair (Balkwill
<xref ref-type="bibr" rid="CR9">2004</xref>
).</p>
<p>Chemokines which comprise the largest family of cytokines lead to migration and activation of leukocytes to sites of infection and also in tumor stroma. In addition, chemokines also stimulate cells causing a release of proteolytic enzymes which help in digesting the extracellular matrix. These alterations open up migratory path for inflammatory cells thereby leading to tumor growth and metastasis. Furthermore, increased production of reactive oxygen and nitrogen species is cardinal feature of inflamed tissues. Nitric oxide and its products have been shown to cause DNA mutations, inhibition of apoptosis, DNA and protein damage and induce angiogenesis. Alveolar macrophages, neutrophils, lymphocytes, fibroblasts, and endothelial cells all mediated release of cytokines, chemokines, and growth factors may act to promote epithelial dysfunction and malignant progression. Epithelial abnormalities induced by smoking may also lead to abnormal inflammatory responses and as initiators of deregulated inflammation. Roles of chemokines IL-8/CXC ligand (CXCL)8 (Yuan et al.
<xref ref-type="bibr" rid="CR190">2000</xref>
), and CXCL5, in human NSCLC have been demonstrated earlier (White et al.
<xref ref-type="bibr" rid="CR177">2003</xref>
). In vitro and in vivo expressions of both CXCL8 and CXCL5 are regulated by COX-2 in NSCLC. Another report demonstrated that COX-2 up-regulates the expression of these chemokines by activating NF-κB nuclear translocation, which led to enhanced NSCLC tumor growth and angiogenesis in vivo (Pold et al.
<xref ref-type="bibr" rid="CR133">2004</xref>
; Williams et al.
<xref ref-type="bibr" rid="CR178">1999</xref>
). Multiple signaling pathways including MAPK and NF-κB can lead to regulation of CXCR2. Alterations in CXCR2 level lead to regulation of cell cycle, apoptosis, and angiogenesis. Interestingly, inhibition of CXCR2 blocked the expansion of early alveolar neoplastic lesions (Wislez et al.
<xref ref-type="bibr" rid="CR179">2006</xref>
).</p>
<p>Cancer is a complex disease involving diverse causes, developmental stages, cell targets and etiologies. It is rooted from and compounded by some degree of genomic instability. Cancer cells share common features that override normal controls on proliferation and homeostasis. In certain systems, the upregulation of NF-κB is associated with advanced stages of oncogenesis, supporting its role in tumor progression. NF-κB activates the expression of genes important for invasion and metastasis which include angiogenic factors like vascular endothelial growth factor (VEGF), proteolytic enzymes such as matrix metalloproteinases, and urokinase plasminogen activator (uPA) (Kunsch and Rosen
<xref ref-type="bibr" rid="CR88">1993</xref>
; Li et al.
<xref ref-type="bibr" rid="CR94">1998</xref>
; Libermann and Baltimore
<xref ref-type="bibr" rid="CR97">1990</xref>
; Novak et al.
<xref ref-type="bibr" rid="CR124">1991</xref>
; Sovak et al.
<xref ref-type="bibr" rid="CR164">1997</xref>
). Elevated circulating levels of both uPA and uPA receptor were found in NSCLC patients with terminal disease (Henneke et al.
<xref ref-type="bibr" rid="CR65">2010</xref>
; Veale et al.
<xref ref-type="bibr" rid="CR170">1990</xref>
). The role of IκB in oncogenesis was first proposed by over expression studies on the antisense IκBα transcripts that transformed mouse NIH3T3 cells to tumorous cells (Beauparlant et al.
<xref ref-type="bibr" rid="CR12">1994</xref>
). Persistent nuclear NF-κB DNA binding and transactivation activity in many human tumors clearly reveal the defective IκB activity. Simultaneously, inverse correlation of IκB levels with oncogenesis has been reported by other groups. These results are consistent with other reports which show that activation of IKK leads to the destruction of IκB factors (Devalaraja et al.
<xref ref-type="bibr" rid="CR33">1999</xref>
; Newton et al.
<xref ref-type="bibr" rid="CR121">1999</xref>
). Thus, IκBα in these studies has been proposed to act as a tumor suppressor to control the oncogenic activation of NF-κB.</p>
<p>Studies reporting reduced cancer risks in patients on anti-inflammatory drugs and the causative roles of proteolytic enzymes, the transcription factor NF-κB, and cytokines such as TNF in potentiating inflammation-based cancer extensively supports this relationship (Coussens and Werb
<xref ref-type="bibr" rid="CR26">2002</xref>
; Greten et al.
<xref ref-type="bibr" rid="CR55">2004</xref>
; Pikarsky et al.
<xref ref-type="bibr" rid="CR132">2004</xref>
). The switching from non-transformed to cancer cells can be epigenetic in response to transient inflammatory signals via a positive feedback loop involving NF-κB and STAT3. STAT-3 directly activates miR-21 and miR-181b-1, which inhibit PTEN and CYLD tumor suppressors, leading to increased NF-κB activity required to maintain the transformed state. These STAT3-mediated regulatory circuits are required for the transformed state in diverse cell lines and tumor growth in xenografts, and their transcriptional signatures are observed in colon adenocarcinomas. Thus, the epigenetic switch involving miR-21, miR-181b-1, PTEN, and CYLD is part of the positive feedback loop that underlies the epigenetic switch which links inflammation to cancer via NF-κB (Iliopoulos et al.
<xref ref-type="bibr" rid="CR69">2010</xref>
).</p>
<p>In pulmonary diseases, the greatest risk for lung cancer is associated with COPD. Tobacco smoking is considered the major cause for COPD. Tobacco smoking provides persistent network of inflammatory stimuli for COPD and this gives the environment for epithelial–mesenchymal transition and cancer progression (Engels
<xref ref-type="bibr" rid="CR42">2008</xref>
; Sasco et al.
<xref ref-type="bibr" rid="CR148">2004</xref>
; Smith et al.
<xref ref-type="bibr" rid="CR162">2006</xref>
). This will eventually lead to loss of host immune functions to both infections and tumor formation.</p>
</sec>
</sec>
<sec id="Sec22">
<title>NF-κB as Therapeutic Target: Pharmacological and Dietary Inhibitors</title>
<p>The mechanism by which inflammation affects the apoptosis is centered around NF-κB, which can be activated by diverse stimuli including proinflammatory cytokines, infectious agents and cellular stresses (Wang and Cho
<xref ref-type="bibr" rid="CR175">2010</xref>
). Therefore, the NF-κB signaling pathway has also provided a focus for pharmacological intervention in cancer where the pathway is often constitutively active and plays a key role in the disease. Concomitantly, NF-κB inhibition by pharmacological and molecular means sensitizes cancer cells with active NF-κB to chemically induced oxidative stress and death (Meng et al.
<xref ref-type="bibr" rid="CR109">2010</xref>
). More than 750 inhibitors of the NF-κB pathway have been identified, including a variety of natural and synthetic molecules. These compounds include antioxidants, peptides, small RNA/DNA, microbial and viral proteins, small molecules, and engineered dominant-negative or constitutively active polypeptides (Gilmore and Herscovitch
<xref ref-type="bibr" rid="CR52">2006</xref>
) (Table 
<xref rid="Tab2" ref-type="table">2</xref>
). Several of these molecules act as general inhibitors of NF-κB induction, whereas others inhibit specific pathways of induction. The NF-κB pathway can be targeted by inhibition of proteasome function to prevent IκB degradation, degradation-resistant IκB proteins, glucocorticoid-mediated repression of the NF-κB pathway, nonsteroidal anti-inflammatory drugs, and other immunosuppressive agents. Cyclopentenone prostaglandins and natural products such as flavonoids also inhibit the NF-κB pathway (Yamamoto and Gaynor
<xref ref-type="bibr" rid="CR184">2001</xref>
).</p>
<p>Bortezomib/Velcade is a highly specific inhibitor of the proteasome, and is currently approved for treatment of multiple myeloma (Richardson et al.
<xref ref-type="bibr" rid="CR140">2004</xref>
). Similarly disulfiram, olmesartan and dithiocarbamates can also inhibit the NF-κB signaling cascade in a similar manner (Cvek and Dvorak
<xref ref-type="bibr" rid="CR27">2007</xref>
). Bortezomib is a dipeptidyl boronic acid that can selectively and specifically inhibit 26S proteasome. By inhibiting proteasome, bortezomib reduces NF-κB activity and Bcl-2 and Bcl-xL levels thereby leading to growth arrest of cancer cells, impaired angiogenesis, decreased metastasis and increased susceptibility to chemotherapy (Table 
<xref rid="Tab2" ref-type="table">2</xref>
). It is the first Food and Drug Administration (FDA) approved proteasome inhibitor. It has been evaluated for frontline and second line therapy for NSCLC and SCLC. Bortezomib as a monotherapy and in combination with other cytotoxic drugs has shown promising results. Bortezomib, although being a FDA approved drug for multiple myeloma, it’s efficacy in different other cancers such as mantle cell and follicular non-Hodgkin’s lymphoma, peripheral T-cell lymphoma, Waldenström’s macroglobulinemia, chronic lymphocytic leukemia, prostate cancer, ovarian cancer is still being evaluated. Nevertheless in combination with other drugs, bortezomib shows some degree of activity while keeping toxicity in manageable range. To date, at least 534 clinical trials using bortezomib alone or in combination have been registered in the US (source: clinicaltrials.gov database, accessed 18 Feb 2011) against almost all resistant cancers including solid tumors such as melanoma, malignant glioma, kidney, colon, breast, lung, pancreas and head or neck cancers, as well as hematological malignancies. The 33 studies of phase I and II, that are particularly looking for its use in lung cancer, mainly NSCLC at various stages and treatment conditions, have decided its dose and tolerability in addition to efficacy. Bortezomib has also been evaluated as a co-treatment with other chemotherapies such as docetaxel, cetuximab (Lilenbaum et al.
<xref ref-type="bibr" rid="CR98">2009</xref>
); pemetrexed (Scagliotti et al.
<xref ref-type="bibr" rid="CR150">2010</xref>
); carboplatin, paclitaxel or radiotherapy (Edelman et al.
<xref ref-type="bibr" rid="CR40">2010</xref>
); gemcitabine, cisplatin (Voortman et al.
<xref ref-type="bibr" rid="CR173">2007</xref>
) and docetaxel (Lara et al.
<xref ref-type="bibr" rid="CR90">2006</xref>
). A study using Bortezomib plus gemcitabine/carboplatin resulted in a notable survival benefit in patients with advanced NSCLC in phase I (Davies et al.
<xref ref-type="bibr" rid="CR28">2008</xref>
) and phase II trials (Davies et al.
<xref ref-type="bibr" rid="CR29">2009</xref>
).</p>
<p>Nonsteroidal anti-inflammatory drugs and glucocorticoids have shown activity against different cancer models through the induction of apoptosis and growth arrest, which is most possibly due to inhibition of NF-κB (Yamamoto and Gaynor
<xref ref-type="bibr" rid="CR184">2001</xref>
). Cyclosporin A and tacrolimus (FK-506) are immunosuppressive agents used in organ transplantation to prevent graft-versus-host disease. These agents can prevent NF-κB activation under specific conditions by inhibiting the activity of calcineurin, a calcium- and calmodulin-dependent serine/threonine phosphatase (Frantz et al.
<xref ref-type="bibr" rid="CR47">1994</xref>
; Meyer et al.
<xref ref-type="bibr" rid="CR113">1997</xref>
; Venkataraman et al.
<xref ref-type="bibr" rid="CR171">1995</xref>
). Proteasome inhibitors such as peptide aldehydes, including MG101, MG132, and MG115, make up a class of agents that inhibit the protease activity of the proteasome, while other class, including lactacystin, block protein degradation activity by acylating a threonine residue in one of the key proteasome subunits.</p>
<p>Natural compounds like edible plant-derived flavonoids exhibit a variety of biological activities, including suppression of inflammation, cancer chemoprevention, and protection from vascular disease. Reports suggest that the properties of the flavonoids quercetin, resveratrol, myricetin, fisetin and apigenin may be mediated through downregulation of the NF-κB pathway (Holmes-McNary and Baldwin
<xref ref-type="bibr" rid="CR67">2000</xref>
; Tsai et al.
<xref ref-type="bibr" rid="CR168">1999</xref>
). Thiocolchicoside, a semisynthetic colchicoside from the plant
<italic>Gloriosa superba</italic>
, inhibits proliferation of leukemia, myeloma, squamous cell carcinoma, breast, colon, and kidney cancer cells, induces apoptosis and suppresses formation of tumor colonies, through inhibition of NF-κB and NF-κB-regulated gene products (Reuter et al.
<xref ref-type="bibr" rid="CR139">2010</xref>
). One of the more extensively studied compounds in this group is curcumin, a diferuloylmethane derived from turmeric, which has been shown to suppress NF-κB activation and NF-κB-dependent gene expression (Anto et al.
<xref ref-type="bibr" rid="CR2">2002</xref>
; Mukhopadhyay et al.
<xref ref-type="bibr" rid="CR118">2001</xref>
; Shishodia et al.
<xref ref-type="bibr" rid="CR161">2005</xref>
). Nimbolide, a triterpenoid isolated from
<italic>Azadirachta indica</italic>
, enhanced the apoptosis induced by inflammatory cytokines and chemotherapeutic agents in tumor cells. This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), by inhibition of NF-κB activation, induced by carcinogens and inflammatory stimuli (Gupta et al.
<xref ref-type="bibr" rid="CR56">2010</xref>
). Naturally occurring isothiocyanates such as allyl isothiocyanate, benzyl isothiocyanate (BITC), phenethyl isothiocyanate and sulphoraphane have been shown to offer protection against chemically induced cancers in experimental animals (Conaway et al.
<xref ref-type="bibr" rid="CR25">2002</xref>
; Fimognari and Hrelia
<xref ref-type="bibr" rid="CR46">2007</xref>
; Hecht
<xref ref-type="bibr" rid="CR63">2000</xref>
). BITC treatment led to decrease in NF-κB transcriptional activity and κB-DNA binding of p65 in BITC-treated pancreatic cancer cell lines, B×PC-3 and Capan-2 cells, while decreasing NF-κB/p65 phosphorylation at Ser536. This was concomitant with reduced HDAC activity and cyclin D1 expression (Batra et al.
<xref ref-type="bibr" rid="CR11">2010</xref>
).</p>
<p>Agents which can interfere with dimerization of NF-κB family members can also be possible therapeutic targets in near future (Gilmore and Herscovitch
<xref ref-type="bibr" rid="CR52">2006</xref>
). In vitro use of trans-dominant p50 mutants in this line has already been reported, however further studies in this area of intervention are still warranted (Logeat et al.
<xref ref-type="bibr" rid="CR102">1991</xref>
). Furthermore, compounds which can target specific posttranslational modification of NF-κB can provide exquisite specificity by regulating its transactivation related to specific gene. Few compounds have been shown to specifically block p65 phosphorylation, these include mesuol (Marquez et al.
<xref ref-type="bibr" rid="CR106">2005</xref>
), pertussis (Iordanskiy et al.
<xref ref-type="bibr" rid="CR70">2002</xref>
), mesalamine (Egan et al.
<xref ref-type="bibr" rid="CR41">1999</xref>
). Another, challenging aspect with regard to therapeutic intervention is to identify the molecules/compounds which can inhibit distinct NF-κB complexes in various experimental models/cell types upon specific stimulation. Preliminary efforts in this respect have been made by Choi et al.
<xref ref-type="bibr" rid="CR22">2004</xref>
and Isomura and Morita
<xref ref-type="bibr" rid="CR71">2006</xref>
using antisense oligonucleotides to Rel A. Since RelA is the most common subunit in most of the systems, the effectiveness of this approach in various diseased conditions is not clear and needs further study. Alternatively, low dose multi drug (combined use of inhibitors) approach seems promising as it may target multiple steps of NF-κB pathway with reduced side effects. One of the examples, in this context, will be thiol reactive compounds which can target the upstream kinase IKK of NF-κB as well as DNA binding of this transcriptional factor. Keeping in view that the pharmacological and natural compounds targeting NF-κB show very encouraging results against various carcinomas, it is quite likely that they can be effective to a measurable degree against lung cancer.</p>
</sec>
<sec id="Sec23">
<title>Future Perspectives</title>
<p>Inspite of several advances in the saga of NF-κB, the future progress will certainly be in the direction of resolving mysteries related to regulation of signaling pathways in pathology and disease, and its therapeutic potential using various model systems. Inspite of abundant literature available regarding signaling pathways associated with NF-κB, very scant information is available regarding the role of various dimeric forms of NF-κB family members in different conditions. We can expect to see more reports in this understudied area of NF-κB in recent years. Another area of future investigations would be to explore the possibility of the application of NF-κB inhibitors topically or local use, e.g., during skin inflammation or airway inflammation, respectively. Intervention by external agents to regulate post-translational modification of NF-κB is another area which has been scantily explored.</p>
<p>Numerous reports discuss about the regulation of NF-κB in response to infection with various pathogens. Recent advances using conditional knockout mice may reveal interesting and novel role(s) of NF-κB family members. Besides the complexity in understanding the signaling pathways, NF-κB will still remain the focus of therapeutic intervention under various diseased conditions including pulmonary infection and cancer. Furthermore, in future we may expect to see more studies using combined therapy, which may prove to be more effective and beneficial by targeting multiple steps at low doses.</p>
</sec>
<sec id="Sec24">
<title>Summary</title>
<p>The transcription factor NF-κB has been linked to several metabolic and inflammatory diseases including various types of cancer and has increased our understanding about the regulation of inflammation and chronic diseases. NF-κB has also been shown to involve in resistance to multiple drug therapy by having various degrees of activity in
<italic>induction</italic>
such as epigenetic switching,
<italic>promotion</italic>
by free radical generation and cellular stress responses, and
<italic>maintenance</italic>
by antagonizing tumor suppressor gene products and apoptosis. In the specific case of lung cancer induced by inflammation due to habitual or environmental causes like cigarette smoking, NF-κB is a pertinent regulatory hub that can be manipulated for better disease management. The major therapeutic challenge in cancer therapy is to determine molecules that destroy only cancer cells and cause minimal harm to somatic cells, as NF-κB is a regulatory molecule in almost all cells. Most of the studies are done in cell cultures and in animal models which do not usually explain the human system and it is extremely difficult to pass the preclinical studies. Therefore, better understanding of NF-κB regulation (post-translational modifications and dimerization in particular) in inflammation and lung cancer is of importance to define promising pharmacological and natural inhibitors for the treatment/management of disease.</p>
</sec>
</body>
<back>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcamo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mizgerd</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Horwitz</surname>
<given-names>BH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment</article-title>
<source>J Immunol</source>
<year>2001</year>
<volume>167</volume>
<fpage>1592</fpage>
<lpage>1600</lpage>
<pub-id pub-id-type="pmid">11466381</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anto</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Denning</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl</article-title>
<source>Carcinogenesis</source>
<year>2002</year>
<volume>23</volume>
<fpage>143</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1093/carcin/23.1.143</pub-id>
<pub-id pub-id-type="pmid">11756235</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arcavi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Benowitz</surname>
<given-names>NL</given-names>
</name>
</person-group>
<article-title>Cigarette smoking and infection</article-title>
<source>Arch Intern Med</source>
<year>2004</year>
<volume>164</volume>
<fpage>2206</fpage>
<lpage>2216</lpage>
<pub-id pub-id-type="doi">10.1001/archinte.164.20.2206</pub-id>
<pub-id pub-id-type="pmid">15534156</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arenzana-Seisdedos</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Turpin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm</article-title>
<source>J Cell Sci</source>
<year>1997</year>
<volume>110</volume>
<issue>Pt 3</issue>
<fpage>369</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="pmid">9057089</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aydin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sanlioglu</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Bisgin</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NF-kappaB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL</article-title>
<source>BMC Cancer</source>
<year>2010</year>
<volume>10</volume>
<fpage>584</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2407-10-584</pub-id>
<pub-id pub-id-type="pmid">20977779</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baeuerle</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Henkel</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Function and activation of NF-kappa B in the immune system</article-title>
<source>Annu Rev Immunol</source>
<year>1994</year>
<volume>12</volume>
<fpage>141</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.iy.12.040194.001041</pub-id>
<pub-id pub-id-type="pmid">8011280</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balamayooran</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fessler</surname>
<given-names>MB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mechanisms of neutrophil accumulation in the lungs against bacteria</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>2010</year>
<volume>43</volume>
<fpage>5</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1165/rcmb.2009-0047TR</pub-id>
<pub-id pub-id-type="pmid">19738160</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldwin</surname>
<given-names>AS</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>The NF-kappa B and I kappa B proteins: new discoveries and insights</article-title>
<source>Annu Rev Immunol</source>
<year>1996</year>
<volume>14</volume>
<fpage>649</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.immunol.14.1.649</pub-id>
<pub-id pub-id-type="pmid">8717528</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balkwill</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Cancer and the chemokine network</article-title>
<source>Nat Rev Cancer</source>
<year>2004</year>
<volume>4</volume>
<fpage>540</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="doi">10.1038/nrc1388</pub-id>
<pub-id pub-id-type="pmid">15229479</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barkett</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gilmore</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Control of apoptosis by Rel/NF-kappaB transcription factors</article-title>
<source>Oncogene</source>
<year>1999</year>
<volume>18</volume>
<fpage>6910</fpage>
<lpage>6924</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1203238</pub-id>
<pub-id pub-id-type="pmid">10602466</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sahu</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Kandala</surname>
<given-names>PK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells</article-title>
<source>Mol Cancer Ther</source>
<year>2010</year>
<volume>9</volume>
<fpage>1596</fpage>
<lpage>1608</lpage>
<pub-id pub-id-type="doi">10.1158/1535-7163.MCT-09-1146</pub-id>
<pub-id pub-id-type="pmid">20484017</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beauparlant</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bitar</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation</article-title>
<source>Oncogene</source>
<year>1994</year>
<volume>9</volume>
<fpage>3189</fpage>
<lpage>3197</lpage>
<pub-id pub-id-type="pmid">7936641</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blank</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kourilsky</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Israel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats</article-title>
<source>Trends Biochem Sci</source>
<year>1992</year>
<volume>17</volume>
<fpage>135</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/0968-0004(92)90321-Y</pub-id>
<pub-id pub-id-type="pmid">1533967</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boczkowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lisdero</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Lanone</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia</article-title>
<source>FASEB J</source>
<year>1999</year>
<volume>13</volume>
<fpage>1637</fpage>
<lpage>1646</lpage>
<pub-id pub-id-type="pmid">10463956</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burns</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Cigarettes and cigarette smoking</article-title>
<source>Clin Chest Med</source>
<year>1991</year>
<volume>12</volume>
<fpage>631</fpage>
<lpage>642</lpage>
<pub-id pub-id-type="pmid">1747982</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection</article-title>
<source>J Immunol</source>
<year>2009</year>
<volume>183</volume>
<fpage>6629</fpage>
<lpage>6638</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0901033</pub-id>
<pub-id pub-id-type="pmid">19846873</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zemans</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>SK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Myeloid differentiation protein-2-dependent and -independent neutrophil accumulation during Escherichia coli pneumonia</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>2009</year>
<volume>40</volume>
<fpage>701</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1165/rcmb.2008-0152OC</pub-id>
<pub-id pub-id-type="pmid">18988922</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lira</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CXCL1 regulates pulmonary host defense to Klebsiella infection via CXCL2, CXCL5, NF-kappaB, and MAPKs</article-title>
<source>J Immunol</source>
<year>2010</year>
<volume>185</volume>
<fpage>6214</fpage>
<lpage>6225</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0903843</pub-id>
<pub-id pub-id-type="pmid">20937845</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views</article-title>
<source>Oncogene</source>
<year>1999</year>
<volume>18</volume>
<fpage>6845</fpage>
<lpage>6852</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1203224</pub-id>
<pub-id pub-id-type="pmid">10602460</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>WC</given-names>
</name>
</person-group>
<article-title>Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB</article-title>
<source>EMBO J</source>
<year>2002</year>
<volume>21</volume>
<fpage>6539</fpage>
<lpage>6548</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/cdf660</pub-id>
<pub-id pub-id-type="pmid">12456660</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blockage of NF-κB by IKKβ- or RelA-siRNA rather than the NF-κB super-suppressor IκBα mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells</article-title>
<source>J Cell Biochem</source>
<year>2008</year>
<volume>105</volume>
<fpage>554</fpage>
<lpage>561</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.21856</pub-id>
<pub-id pub-id-type="pmid">18636537</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>IW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>HM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-kappaB inhibits established asthmatic reaction in mice</article-title>
<source>Int Immunopharmacol</source>
<year>2004</year>
<volume>4</volume>
<fpage>1817</fpage>
<lpage>1828</lpage>
<pub-id pub-id-type="doi">10.1016/j.intimp.2004.07.030</pub-id>
<pub-id pub-id-type="pmid">15531297</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Churg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zay</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shay</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>2002</year>
<volume>27</volume>
<fpage>368</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="pmid">12204900</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collart</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Baeuerle</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vassalli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B</article-title>
<source>Mol Cell Biol</source>
<year>1990</year>
<volume>10</volume>
<fpage>1498</fpage>
<lpage>1506</lpage>
<pub-id pub-id-type="pmid">2181276</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conaway</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>FL</given-names>
</name>
</person-group>
<article-title>Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans</article-title>
<source>Curr Drug Metab</source>
<year>2002</year>
<volume>3</volume>
<fpage>233</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.2174/1389200023337496</pub-id>
<pub-id pub-id-type="pmid">12083319</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coussens</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Werb</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Inflammation and cancer</article-title>
<source>Nature</source>
<year>2002</year>
<volume>420</volume>
<fpage>860</fpage>
<lpage>867</lpage>
<pub-id pub-id-type="doi">10.1038/nature01322</pub-id>
<pub-id pub-id-type="pmid">12490959</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cvek</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dvorak</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals</article-title>
<source>Curr Pharm Des</source>
<year>2007</year>
<volume>13</volume>
<fpage>3155</fpage>
<lpage>3167</lpage>
<pub-id pub-id-type="doi">10.2174/138161207782110390</pub-id>
<pub-id pub-id-type="pmid">17979756</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ruel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lara</surname>
<given-names>PN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study</article-title>
<source>J Thorac Oncol</source>
<year>2008</year>
<volume>3</volume>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1097/JTO.0b013e31815e8b88</pub-id>
<pub-id pub-id-type="pmid">18166843</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Chansky</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lara</surname>
<given-names>PN</given-names>
<suffix>Jr</suffix>
</name>
<etal></etal>
</person-group>
<article-title>Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339)</article-title>
<source>J Thorac Oncol</source>
<year>2009</year>
<volume>4</volume>
<fpage>87</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1097/JTO.0b013e3181915052</pub-id>
<pub-id pub-id-type="pmid">19096312</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delhase</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation</article-title>
<source>Science</source>
<year>1999</year>
<volume>284</volume>
<fpage>309</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1126/science.284.5412.309</pub-id>
<pub-id pub-id-type="pmid">10195894</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>β-catenin interacts with and inhibits NF-κB in human colon and breast cancer</article-title>
<source>Cancer Cell</source>
<year>2002</year>
<volume>2</volume>
<fpage>323</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1016/S1535-6108(02)00154-X</pub-id>
<pub-id pub-id-type="pmid">12398896</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denlinger</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Rundall</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>MD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis</article-title>
<source>Ann Thorac Surg</source>
<year>2004</year>
<volume>78</volume>
<fpage>1207</fpage>
<lpage>1214</lpage>
<pub-id pub-id-type="pmid">15464472</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devalaraja</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>DZ</given-names>
</name>
<name>
<surname>Ballard</surname>
<given-names>DW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription</article-title>
<source>Cancer Res</source>
<year>1999</year>
<volume>59</volume>
<fpage>1372</fpage>
<lpage>1377</lpage>
<pub-id pub-id-type="pmid">10096573</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiDonato</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rothwarf</surname>
<given-names>DM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB</article-title>
<source>Nature</source>
<year>1997</year>
<volume>388</volume>
<fpage>548</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="doi">10.1038/41493</pub-id>
<pub-id pub-id-type="pmid">9252186</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Driscoll</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Hassenbein</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>BW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cloning, expression, and functional characterization of rat MIP-2: a neutrophil chemoattractant and epithelial cell mitogen</article-title>
<source>J Leukoc Biol</source>
<year>1995</year>
<volume>58</volume>
<fpage>359</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="pmid">7665992</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunn</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Coles</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>RK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Requirement for nuclear factor (NF)-kappa B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter</article-title>
<source>Blood</source>
<year>1994</year>
<volume>83</volume>
<fpage>2469</fpage>
<lpage>2479</lpage>
<pub-id pub-id-type="pmid">7513199</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duran</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Diaz-Meco</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Moscat</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-κB transcriptional activation</article-title>
<source>EMBO J</source>
<year>2003</year>
<volume>22</volume>
<fpage>3910</fpage>
<lpage>3918</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/cdg370</pub-id>
<pub-id pub-id-type="pmid">12881425</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutta</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Current insights into the regulation of programmed cell death by NF-kappaB</article-title>
<source>Oncogene</source>
<year>2006</year>
<volume>25</volume>
<fpage>6800</fpage>
<lpage>6816</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1209938</pub-id>
<pub-id pub-id-type="pmid">17072329</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ea</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Regulation of NF-kappaB activity through lysine monomethylation of p65</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>2009</year>
<volume>106</volume>
<fpage>18972</fpage>
<lpage>18977</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0910439106</pub-id>
<pub-id pub-id-type="pmid">19864627</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edelman</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Burrows</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Krasna</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer</article-title>
<source>Lung Cancer</source>
<year>2010</year>
<volume>68</volume>
<fpage>84</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1016/j.lungcan.2009.05.003</pub-id>
<pub-id pub-id-type="pmid">19540615</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egan</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Mays</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Huntoon</surname>
<given-names>CJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity</article-title>
<source>J Biol Chem</source>
<year>1999</year>
<volume>274</volume>
<fpage>26448</fpage>
<lpage>26453</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.274.37.26448</pub-id>
<pub-id pub-id-type="pmid">10473604</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engels</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Inflammation in the development of lung cancer: epidemiological evidence</article-title>
<source>Expert Rev Anticancer Ther</source>
<year>2008</year>
<volume>8</volume>
<fpage>605</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="doi">10.1586/14737140.8.4.605</pub-id>
<pub-id pub-id-type="pmid">18402527</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ertel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>The differential effect of cigarette smoke on the growth of bacteria found in humans</article-title>
<source>Chest</source>
<year>1991</year>
<volume>100</volume>
<fpage>628</fpage>
<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1378/chest.100.3.628</pub-id>
<pub-id pub-id-type="pmid">1889244</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faggioni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gatti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Demitri</surname>
<given-names>MT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema</article-title>
<source>J Lab Clin Med</source>
<year>1994</year>
<volume>123</volume>
<fpage>394</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="pmid">8133151</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The membrane protein of SARS-CoV suppresses NF-κB activation</article-title>
<source>J Med Virol</source>
<year>2007</year>
<volume>79</volume>
<fpage>1431</fpage>
<lpage>1439</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.20953</pub-id>
<pub-id pub-id-type="pmid">17705188</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fimognari</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hrelia</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Sulforaphane as a promising molecule for fighting cancer</article-title>
<source>Mutat Res</source>
<year>2007</year>
<volume>635</volume>
<fpage>90</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1016/j.mrrev.2006.10.004</pub-id>
<pub-id pub-id-type="pmid">17134937</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frantz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nordby</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Bren</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B</article-title>
<source>EMBO J</source>
<year>1994</year>
<volume>13</volume>
<fpage>861</fpage>
<lpage>870</lpage>
<pub-id pub-id-type="pmid">8112299</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frode-Saleh</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Calixto</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>Synergistic antiinflammatory effect of NF-kappaB inhibitors and steroidal or non steroidal antiinflammatory drugs in the pleural inflammation induced by carrageenan in mice</article-title>
<source>Inflamm Res</source>
<year>2000</year>
<volume>49</volume>
<fpage>330</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="doi">10.1007/PL00000213</pub-id>
<pub-id pub-id-type="pmid">10959554</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>May</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>EB</given-names>
</name>
</person-group>
<article-title>NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses</article-title>
<source>Annu Rev Immunol</source>
<year>1998</year>
<volume>16</volume>
<fpage>225</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.immunol.16.1.225</pub-id>
<pub-id pub-id-type="pmid">9597130</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilmore</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>NF-kappa B, KBF1, dorsal, and related matters</article-title>
<source>Cell</source>
<year>1990</year>
<volume>62</volume>
<fpage>841</fpage>
<lpage>843</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(90)90257-F</pub-id>
<pub-id pub-id-type="pmid">2203533</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilmore</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Introduction to NF-kappaB: players, pathways, perspectives</article-title>
<source>Oncogene</source>
<year>2006</year>
<volume>25</volume>
<fpage>6680</fpage>
<lpage>6684</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1209954</pub-id>
<pub-id pub-id-type="pmid">17072321</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilmore</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Herscovitch</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Inhibitors of NF-kappaB signaling: 785 and counting</article-title>
<source>Oncogene</source>
<year>2006</year>
<volume>25</volume>
<fpage>6887</fpage>
<lpage>6899</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1209982</pub-id>
<pub-id pub-id-type="pmid">17072334</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giuliani</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bucci</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nf-kB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications</article-title>
<source>Clin Ter</source>
<year>2001</year>
<volume>152</volume>
<fpage>249</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="pmid">11725618</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glozak</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Seto</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Histone deacetylases and cancer</article-title>
<source>Oncogene</source>
<year>2007</year>
<volume>26</volume>
<fpage>5420</fpage>
<lpage>5432</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1210610</pub-id>
<pub-id pub-id-type="pmid">17694083</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greten</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Eckmann</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Greten</surname>
<given-names>TF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer</article-title>
<source>Cell</source>
<year>2004</year>
<volume>118</volume>
<fpage>285</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2004.07.013</pub-id>
<pub-id pub-id-type="pmid">15294155</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reuter</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modification of cysteine 179 of IκBα kinase by nimbolide leads to down-regulation of NF-κB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents</article-title>
<source>J Biol Chem</source>
<year>2010</year>
<volume>285</volume>
<fpage>35406</fpage>
<lpage>35417</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.161984</pub-id>
<pub-id pub-id-type="pmid">20829362</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hajjar</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Harowicz</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liggitt</surname>
<given-names>HD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An essential role for non-bone marrow-derived cells in control of
<italic>Pseudomonas aeruginosa</italic>
pneumonia</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>2005</year>
<volume>33</volume>
<fpage>470</fpage>
<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1165/rcmb.2005-0199OC</pub-id>
<pub-id pub-id-type="pmid">16100080</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ritzenthaler</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3 K and NF-kappaB signals</article-title>
<source>Am J Physiol Lung Cell Mol Physiol</source>
<year>2008</year>
<volume>294</volume>
<fpage>L1238</fpage>
<lpage>L1249</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00017.2008</pub-id>
<pub-id pub-id-type="pmid">18390835</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harant</surname>
<given-names>H</given-names>
</name>
<name>
<surname>de Martin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Andrew</surname>
<given-names>PJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor-alpha involves the transcription factor NF-kappaB</article-title>
<source>J Biol Chem</source>
<year>1996</year>
<volume>271</volume>
<fpage>26954</fpage>
<lpage>26961</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.271.43.26954</pub-id>
<pub-id pub-id-type="pmid">8900181</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasday</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Bascom</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bacterial endotoxin is an active component of cigarette smoke</article-title>
<source>Chest</source>
<year>1999</year>
<volume>115</volume>
<fpage>829</fpage>
<lpage>835</lpage>
<pub-id pub-id-type="doi">10.1378/chest.115.3.829</pub-id>
<pub-id pub-id-type="pmid">10084499</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hatada</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Nieters</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wulczyn</surname>
<given-names>FG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>1992</year>
<volume>89</volume>
<fpage>2489</fpage>
<lpage>2493</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.89.6.2489</pub-id>
<pub-id pub-id-type="pmid">1532257</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayden</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Signaling to NF-kappaB</article-title>
<source>Genes Dev</source>
<year>2004</year>
<volume>18</volume>
<fpage>2195</fpage>
<lpage>2224</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1228704</pub-id>
<pub-id pub-id-type="pmid">15371334</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hecht</surname>
<given-names>SS</given-names>
</name>
</person-group>
<article-title>Inhibition of carcinogenesis by isothiocyanates</article-title>
<source>Drug Metab Rev</source>
<year>2000</year>
<volume>32</volume>
<fpage>395</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="doi">10.1081/DMR-100102342</pub-id>
<pub-id pub-id-type="pmid">11139137</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hein</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schluter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kulke</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene</article-title>
<source>Biochem Biophys Res Commun</source>
<year>1997</year>
<volume>237</volume>
<fpage>537</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.1997.7169</pub-id>
<pub-id pub-id-type="pmid">9299399</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henneke</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Greschus</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Savai</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model</article-title>
<source>Am J Respir Crit Care Med</source>
<year>2010</year>
<volume>181</volume>
<fpage>611</fpage>
<lpage>619</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.200903-0342OC</pub-id>
<pub-id pub-id-type="pmid">20056905</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hewson</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>NW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways</article-title>
<source>Eur Respir J</source>
<year>2010</year>
<volume>36</volume>
<fpage>1425</fpage>
<lpage>1435</lpage>
<pub-id pub-id-type="doi">10.1183/09031936.00026910</pub-id>
<pub-id pub-id-type="pmid">20525715</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes-McNary</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baldwin</surname>
<given-names>AS</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase</article-title>
<source>Cancer Res</source>
<year>2000</year>
<volume>60</volume>
<fpage>3477</fpage>
<lpage>3483</lpage>
<pub-id pub-id-type="pmid">10910059</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikeda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2000</year>
<volume>272</volume>
<fpage>375</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.2000.2786</pub-id>
<pub-id pub-id-type="pmid">10833421</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iliopoulos</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jaeger</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>HA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>STAT3 activation of miR-21 and miR-181b–1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer</article-title>
<source>Mol Cell</source>
<year>2010</year>
<volume>39</volume>
<fpage>493</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2010.07.023</pub-id>
<pub-id pub-id-type="pmid">20797623</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iordanskiy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Iordanskaya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Quivy</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity</article-title>
<source>Virology</source>
<year>2002</year>
<volume>302</volume>
<fpage>195</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1006/viro.2002.1618</pub-id>
<pub-id pub-id-type="pmid">12429528</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isomura</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides</article-title>
<source>Microbiol Immunol</source>
<year>2006</year>
<volume>50</volume>
<fpage>559</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="pmid">16924140</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeong</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Radonovich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>JN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity</article-title>
<source>Blood</source>
<year>2004</year>
<volume>104</volume>
<fpage>1490</fpage>
<lpage>1497</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2003-12-4174</pub-id>
<pub-id pub-id-type="pmid">15155458</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeyaseelan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Manzer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>SK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against
<italic>Escherichia coli</italic>
lipopolysaccharide and viable
<italic>Escherichia coli</italic>
</article-title>
<source>J Immunol</source>
<year>2005</year>
<volume>175</volume>
<fpage>7484</fpage>
<lpage>7495</lpage>
<pub-id pub-id-type="pmid">16301656</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeyaseelan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against
<italic>Klebsiella pneumoniae</italic>
but not
<italic>Pseudomonas aeruginosa</italic>
</article-title>
<source>J Immunol</source>
<year>2006</year>
<volume>177</volume>
<fpage>538</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="pmid">16785551</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeyaseelan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Fessler</surname>
<given-names>MB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during
<italic>Escherichia coli</italic>
pneumonia</article-title>
<source>J Immunol</source>
<year>2007</year>
<volume>178</volume>
<fpage>3153</fpage>
<lpage>3160</lpage>
<pub-id pub-id-type="pmid">17312163</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Van Antwerp</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hope</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha</article-title>
<source>EMBO J</source>
<year>1999</year>
<volume>18</volume>
<fpage>6682</fpage>
<lpage>6693</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/18.23.6682</pub-id>
<pub-id pub-id-type="pmid">10581242</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Simms</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Lupa</surname>
<given-names>MM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia</article-title>
<source>J Immunol</source>
<year>2005</year>
<volume>175</volume>
<fpage>7530</fpage>
<lpage>7535</lpage>
<pub-id pub-id-type="pmid">16301661</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joo</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Jetten</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms involved in farnesol-induced apoptosis</article-title>
<source>Cancer Lett</source>
<year>2010</year>
<volume>287</volume>
<fpage>123</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1016/j.canlet.2009.05.015</pub-id>
<pub-id pub-id-type="pmid">19520495</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapetanovic</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nahori</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Balloy</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of phagocytosis and intracellular sensing for cytokine production by
<italic>Staphylococcus aureus</italic>
-activated macrophages</article-title>
<source>Infect Immun</source>
<year>2007</year>
<volume>75</volume>
<fpage>830</fpage>
<lpage>837</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.01199-06</pub-id>
<pub-id pub-id-type="pmid">17118979</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ben-Neriah</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity</article-title>
<source>Annu Rev Immunol</source>
<year>2000</year>
<volume>18</volume>
<fpage>621</fpage>
<lpage>663</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.immunol.18.1.621</pub-id>
<pub-id pub-id-type="pmid">10837071</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Delhase</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CK2 is a C-terminal IκB kinase responsible for NF-κB activation during the UV response</article-title>
<source>Mol Cell</source>
<year>2003</year>
<volume>12</volume>
<fpage>829</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(03)00358-7</pub-id>
<pub-id pub-id-type="pmid">14580335</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiernan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bres</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>RW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65</article-title>
<source>J Biol Chem</source>
<year>2003</year>
<volume>278</volume>
<fpage>2758</fpage>
<lpage>2766</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M209572200</pub-id>
<pub-id pub-id-type="pmid">12419806</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Hawke</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Baldwin</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>NF-kappaB and IKK as therapeutic targets in cancer</article-title>
<source>Cell Death Differ</source>
<year>2006</year>
<volume>13</volume>
<fpage>738</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="doi">10.1038/sj.cdd.4401877</pub-id>
<pub-id pub-id-type="pmid">16485028</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinert</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Euchenhofer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ihrig-Biedert</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-kappaB</article-title>
<source>J Biol Chem</source>
<year>1996</year>
<volume>271</volume>
<fpage>6039</fpage>
<lpage>6044</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.271.11.6039</pub-id>
<pub-id pub-id-type="pmid">8626388</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koay</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Christman</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>BH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired pulmonary NF-kappaB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice</article-title>
<source>Infect Immun</source>
<year>2001</year>
<volume>69</volume>
<fpage>5991</fpage>
<lpage>5996</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.69.10.5991-5996.2001</pub-id>
<pub-id pub-id-type="pmid">11553535</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koay</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Washington</surname>
<given-names>MK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>2002</year>
<volume>26</volume>
<fpage>572</fpage>
<lpage>578</lpage>
<pub-id pub-id-type="pmid">11970909</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krug</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Torres-Gonzalez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of NF-κB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis</article-title>
<source>Am J Pathol</source>
<year>2010</year>
<volume>177</volume>
<fpage>608</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="doi">10.2353/ajpath.2010.091122</pub-id>
<pub-id pub-id-type="pmid">20566741</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunsch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>NF-kappa B subunit-specific regulation of the interleukin-8 promoter</article-title>
<source>Mol Cell Biol</source>
<year>1993</year>
<volume>13</volume>
<fpage>6137</fpage>
<lpage>6146</lpage>
<pub-id pub-id-type="pmid">8413215</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lancaster</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Christman</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Blackwell</surname>
<given-names>TR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Suppression of lung inflammation in rats by prevention of NF-kappaB activation in the liver</article-title>
<source>Inflammation</source>
<year>2001</year>
<volume>25</volume>
<fpage>25</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1023/A:1007071527408</pub-id>
<pub-id pub-id-type="pmid">11293663</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lara</surname>
<given-names>PN</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Koczywas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>DI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bortezomib plus docetaxel in advanced non-small cell lung cancer and other solid tumors: a phase I California Cancer Consortium trial</article-title>
<source>J Thorac Oncol</source>
<year>2006</year>
<volume>1</volume>
<fpage>126</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="doi">10.1097/01243894-200602000-00005</pub-id>
<pub-id pub-id-type="pmid">17409841</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Burckart</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Nuclear factor kappa B: important transcription factor and therapeutic target</article-title>
<source>J Clin Pharmacol</source>
<year>1998</year>
<volume>38</volume>
<fpage>981</fpage>
<lpage>993</lpage>
<pub-id pub-id-type="doi">10.1177/009127009803801101</pub-id>
<pub-id pub-id-type="pmid">9824778</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lentsch</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Czermak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Bless</surname>
<given-names>NM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>1999</year>
<volume>20</volume>
<fpage>692</fpage>
<lpage>698</lpage>
<pub-id pub-id-type="pmid">10101001</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lernbecher</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Wirth</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation</article-title>
<source>Nature</source>
<year>1993</year>
<volume>365</volume>
<fpage>767</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="doi">10.1038/365767a0</pub-id>
<pub-id pub-id-type="pmid">7692309</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Oberley</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of AP-1 and NF-kappaB by manganese-containing superoxide dismutase in human breast cancer cells</article-title>
<source>FASEB J</source>
<year>1998</year>
<volume>12</volume>
<fpage>1713</fpage>
<lpage>1723</lpage>
<pub-id pub-id-type="pmid">9837861</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>ZW</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis</article-title>
<source>J Exp Med</source>
<year>1999</year>
<volume>189</volume>
<fpage>1839</fpage>
<lpage>1845</lpage>
<pub-id pub-id-type="doi">10.1084/jem.189.11.1839</pub-id>
<pub-id pub-id-type="pmid">10359587</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>He</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>YZ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice</article-title>
<source>Respir Res</source>
<year>2009</year>
<volume>10</volume>
<fpage>79</fpage>
<pub-id pub-id-type="doi">10.1186/1465-9921-10-79</pub-id>
<pub-id pub-id-type="pmid">19706153</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Libermann</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Activation of interleukin-6 gene expression through the NF-kappa B transcription factor</article-title>
<source>Mol Cell Biol</source>
<year>1990</year>
<volume>10</volume>
<fpage>2327</fpage>
<lpage>2334</lpage>
<pub-id pub-id-type="pmid">2183031</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lilenbaum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Randomized phase II trial of docetaxel plus cetuximab or docetaxel plus bortezomib in patients with advanced non-small-cell lung cancer and a performance status of 2: CALGB 30402</article-title>
<source>J Clin Oncol</source>
<year>2009</year>
<volume>27</volume>
<fpage>4487</fpage>
<lpage>4491</lpage>
<pub-id pub-id-type="doi">10.1200/JCO.2009.22.7066</pub-id>
<pub-id pub-id-type="pmid">19704058</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>
<italic>Streptococcus pneumoniae</italic>
synergizes with nontypeable
<italic>Haemophilus influenzae</italic>
to induce inflammation via upregulating TLR2</article-title>
<source>BMC Immunol</source>
<year>2008</year>
<volume>9</volume>
<fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2172-9-40</pub-id>
<pub-id pub-id-type="pmid">18664270</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gewert</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hiscott</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Differential transcriptional activation in vitro by NF-kappa B/Rel proteins</article-title>
<source>J Biol Chem</source>
<year>1995</year>
<volume>270</volume>
<fpage>3123</fpage>
<lpage>3131</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.7.3123</pub-id>
<pub-id pub-id-type="pmid">7852394</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Togo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Al-Mugotir</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NF-kappaB mediates the survival of human bronchial epithelial cells exposed to cigarette smoke extract</article-title>
<source>Respir Res</source>
<year>2008</year>
<volume>9</volume>
<fpage>66</fpage>
<pub-id pub-id-type="doi">10.1186/1465-9921-9-66</pub-id>
<pub-id pub-id-type="pmid">18811964</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Logeat</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Israel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ten</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant</article-title>
<source>EMBO J</source>
<year>1991</year>
<volume>10</volume>
<fpage>1827</fpage>
<lpage>1832</lpage>
<pub-id pub-id-type="pmid">1675604</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>2010</year>
<volume>107</volume>
<fpage>46</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0912493107</pub-id>
<pub-id pub-id-type="pmid">20080798</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mabb</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>SUMO and NF-kappaB ties</article-title>
<source>Cell Mol Life Sci</source>
<year>2007</year>
<volume>64</volume>
<fpage>1979</fpage>
<lpage>1996</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-007-7005-2</pub-id>
<pub-id pub-id-type="pmid">17530464</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacNee</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wiggs</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Belzberg</surname>
<given-names>AS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effect of cigarette smoking on neutrophil kinetics in human lungs</article-title>
<source>N Engl J Med</source>
<year>1989</year>
<volume>321</volume>
<fpage>924</fpage>
<lpage>928</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM198910053211402</pub-id>
<pub-id pub-id-type="pmid">2779614</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marquez</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sancho</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bedoya</surname>
<given-names>LM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway</article-title>
<source>Antiviral Res</source>
<year>2005</year>
<volume>66</volume>
<fpage>137</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1016/j.antiviral.2005.02.006</pub-id>
<pub-id pub-id-type="pmid">15911030</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKay</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Cidlowski</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>CBP (CREB binding protein) integrates NF-κB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism</article-title>
<source>Mol Endocrinol</source>
<year>2000</year>
<volume>14</volume>
<fpage>1222</fpage>
<lpage>1234</lpage>
<pub-id pub-id-type="doi">10.1210/me.14.8.1222</pub-id>
<pub-id pub-id-type="pmid">10935546</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nazzal</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sadikot</surname>
<given-names>RT</given-names>
</name>
</person-group>
<article-title>Cigarette smoking and innate immunity</article-title>
<source>Inflamm Res</source>
<year>2008</year>
<volume>57</volume>
<fpage>497</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1007/s00011-008-8078-6</pub-id>
<pub-id pub-id-type="pmid">19109742</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nuclear factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells</article-title>
<source>Cancer Lett</source>
<year>2010</year>
<volume>299</volume>
<fpage>45</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1016/j.canlet.2010.08.002</pub-id>
<pub-id pub-id-type="pmid">20810208</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercurio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Manning</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>NF-kappaB as a primary regulator of the stress response</article-title>
<source>Oncogene</source>
<year>1999</year>
<volume>18</volume>
<fpage>6163</fpage>
<lpage>6171</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1203174</pub-id>
<pub-id pub-id-type="pmid">10557108</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercurio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>BW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation</article-title>
<source>Science</source>
<year>1997</year>
<volume>278</volume>
<fpage>860</fpage>
<lpage>866</lpage>
<pub-id pub-id-type="doi">10.1126/science.278.5339.860</pub-id>
<pub-id pub-id-type="pmid">9346484</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercurio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Shevchenko</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex</article-title>
<source>Mol Cell Biol</source>
<year>1999</year>
<volume>19</volume>
<fpage>1526</fpage>
<lpage>1538</lpage>
<pub-id pub-id-type="pmid">9891086</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kohler</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Joly</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation</article-title>
<source>FEBS Lett</source>
<year>1997</year>
<volume>413</volume>
<fpage>354</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-5793(97)00930-7</pub-id>
<pub-id pub-id-type="pmid">9280312</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meylan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dooley</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Feldser</surname>
<given-names>DM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma</article-title>
<source>Nature</source>
<year>2009</year>
<volume>462</volume>
<fpage>104</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1038/nature08462</pub-id>
<pub-id pub-id-type="pmid">19847165</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizgerd</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Acute lower respiratory tract infection</article-title>
<source>N Engl J Med</source>
<year>2008</year>
<volume>358</volume>
<fpage>716</fpage>
<lpage>727</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra074111</pub-id>
<pub-id pub-id-type="pmid">18272895</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizgerd</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Lupa</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Kogan</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during
<italic>Escherichia coli</italic>
pneumonia</article-title>
<source>Am J Respir Crit Care Med</source>
<year>2003</year>
<volume>168</volume>
<fpage>810</fpage>
<lpage>817</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.200303-412OC</pub-id>
<pub-id pub-id-type="pmid">12857723</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mortenson</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Schlieman</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Virudachalam</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line</article-title>
<source>Cancer Chemother Pharmacol</source>
<year>2004</year>
<volume>54</volume>
<fpage>343</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1007/s00280-004-0811-4</pub-id>
<pub-id pub-id-type="pmid">15197486</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukhopadhyay</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bueso-Ramos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines</article-title>
<source>Oncogene</source>
<year>2001</year>
<volume>20</volume>
<fpage>7597</fpage>
<lpage>7609</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1204997</pub-id>
<pub-id pub-id-type="pmid">11753638</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nabel</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>IM</given-names>
</name>
</person-group>
<article-title>Proposed NF-kappa B/I kappa B family nomenclature</article-title>
<source>Genes Dev</source>
<year>1993</year>
<volume>7</volume>
<fpage>2063</fpage>
<pub-id pub-id-type="doi">10.1101/gad.7.11.2063</pub-id>
<pub-id pub-id-type="pmid">8224837</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kadiiska</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Free radical production requires both inducible nitric oxide synthase and xanthine oxidase in LPS-treated skin</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>2006</year>
<volume>103</volume>
<fpage>4616</fpage>
<lpage>4621</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0510352103</pub-id>
<pub-id pub-id-type="pmid">16537416</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newton</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Bhat-Nakshatri</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Negative regulation of transactivation function but not DNA binding of NF-kappaB and AP-1 by IkappaBbeta1 in breast cancer cells</article-title>
<source>J Biol Chem</source>
<year>1999</year>
<volume>274</volume>
<fpage>18827</fpage>
<lpage>18835</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.274.26.18827</pub-id>
<pub-id pub-id-type="pmid">10373501</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>N’Guessan</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Temmesfeld-Wollbruck</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zahlten</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Moraxella catarrhalis induces ERK- and NF-κB-dependent COX-2 and prostaglandin E2 in lung epithelium</article-title>
<source>Eur Respir J</source>
<year>2007</year>
<volume>30</volume>
<fpage>443</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="doi">10.1183/09031936.00008707</pub-id>
<pub-id pub-id-type="pmid">17537778</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nimmerjahn</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dudziak</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dirmeier</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Active NF-κB signalling is a prerequisite for influenza virus infection</article-title>
<source>J Gen Virol</source>
<year>2004</year>
<volume>85</volume>
<issue>Pt 8</issue>
<fpage>2347</fpage>
<lpage>2356</lpage>
<pub-id pub-id-type="doi">10.1099/vir.0.79958-0</pub-id>
<pub-id pub-id-type="pmid">15269376</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novak</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Cocks</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>A labile repressor acts through the NFkB-like binding sites of the human urokinase gene</article-title>
<source>Nucleic Acids Res</source>
<year>1991</year>
<volume>19</volume>
<fpage>3389</fpage>
<lpage>3393</lpage>
<pub-id pub-id-type="doi">10.1093/nar/19.12.3389</pub-id>
<pub-id pub-id-type="pmid">1905804</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opitz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Puschel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schmeck</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized
<italic>Streptococcus pneumoniae</italic>
</article-title>
<source>J Biol Chem</source>
<year>2004</year>
<volume>279</volume>
<fpage>36426</fpage>
<lpage>36432</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M403861200</pub-id>
<pub-id pub-id-type="pmid">15215247</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pahl</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Activators and target genes of Rel/NF-kappaB transcription factors</article-title>
<source>Oncogene</source>
<year>1999</year>
<volume>18</volume>
<fpage>6853</fpage>
<lpage>6866</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1203239</pub-id>
<pub-id pub-id-type="pmid">10602461</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname>
<given-names>ND</given-names>
</name>
</person-group>
<article-title>Achieving transcriptional specificity with NF-kappa B</article-title>
<source>Int J Biochem Cell Biol</source>
<year>1997</year>
<volume>29</volume>
<fpage>1433</fpage>
<lpage>1448</lpage>
<pub-id pub-id-type="doi">10.1016/S1357-2725(97)00088-5</pub-id>
<pub-id pub-id-type="pmid">9570137</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname>
<given-names>ND</given-names>
</name>
</person-group>
<article-title>Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway</article-title>
<source>Oncogene</source>
<year>2006</year>
<volume>25</volume>
<fpage>6717</fpage>
<lpage>6730</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1209937</pub-id>
<pub-id pub-id-type="pmid">17072324</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname>
<given-names>ND</given-names>
</name>
</person-group>
<article-title>Integrating cell-signalling pathways with NF-kappaB and IKK function</article-title>
<source>Nat Rev Mol Cell Biol</source>
<year>2007</year>
<volume>8</volume>
<fpage>49</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1038/nrm2083</pub-id>
<pub-id pub-id-type="pmid">17183360</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Gilmore</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Good cop, bad cop: the different faces of NF-kappaB</article-title>
<source>Cell Death Differ</source>
<year>2006</year>
<volume>13</volume>
<fpage>759</fpage>
<lpage>772</lpage>
<pub-id pub-id-type="doi">10.1038/sj.cdd.4401838</pub-id>
<pub-id pub-id-type="pmid">16410803</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phipps</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Aronoff</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of
<italic>Streptococcus pneumoniae</italic>
</article-title>
<source>Infect Immun</source>
<year>2010</year>
<volume>78</volume>
<fpage>1214</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.00963-09</pub-id>
<pub-id pub-id-type="pmid">20008540</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pikarsky</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Porat</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NF-kappaB functions as a tumour promoter in inflammation-associated cancer</article-title>
<source>Nature</source>
<year>2004</year>
<volume>431</volume>
<fpage>461</fpage>
<lpage>466</lpage>
<pub-id pub-id-type="doi">10.1038/nature02924</pub-id>
<pub-id pub-id-type="pmid">15329734</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pold</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>LX</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer</article-title>
<source>Cancer Res</source>
<year>2004</year>
<volume>64</volume>
<fpage>1853</fpage>
<lpage>1860</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-03-3262</pub-id>
<pub-id pub-id-type="pmid">14996749</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Power</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta in the host response to
<italic>Pseudomonas aeruginosa</italic>
lung infection in mice</article-title>
<source>J Immunol</source>
<year>2007</year>
<volume>178</volume>
<fpage>3170</fpage>
<lpage>3176</lpage>
<pub-id pub-id-type="pmid">17312165</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poynter</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Irvin</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Janssen-Heininger</surname>
<given-names>YM</given-names>
</name>
</person-group>
<article-title>Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation</article-title>
<source>Am J Pathol</source>
<year>2002</year>
<volume>160</volume>
<fpage>1325</fpage>
<lpage>1334</lpage>
<pub-id pub-id-type="doi">10.1016/S0002-9440(10)62559-X</pub-id>
<pub-id pub-id-type="pmid">11943717</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poynter</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Irvin</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Janssen-Heininger</surname>
<given-names>YM</given-names>
</name>
</person-group>
<article-title>A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation</article-title>
<source>J Immunol</source>
<year>2003</year>
<volume>170</volume>
<fpage>6257</fpage>
<lpage>6265</lpage>
<pub-id pub-id-type="pmid">12794158</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinton</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Simms</surname>
<given-names>BT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functions and regulation of NF-kappaB RelA during pneumococcal pneumonia</article-title>
<source>J Immunol</source>
<year>2007</year>
<volume>178</volume>
<fpage>1896</fpage>
<lpage>1903</lpage>
<pub-id pub-id-type="pmid">17237440</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Regnier</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification and characterization of an IkappaB kinase</article-title>
<source>Cell</source>
<year>1997</year>
<volume>90</volume>
<fpage>373</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80344-X</pub-id>
<pub-id pub-id-type="pmid">9244310</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reuter</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Phromnoi</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Thiocolchicoside exhibits anticancer effects through downregulation of NF-κB pathway and its regulated gene products linked to inflammation and cancer</article-title>
<source>Cancer Prev Res</source>
<year>2010</year>
<volume>3</volume>
<fpage>1462</fpage>
<lpage>1472</lpage>
<pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-10-0037</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Hideshima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mitsiades</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proteasome inhibition in hematologic malignancies</article-title>
<source>Ann Med</source>
<year>2004</year>
<volume>36</volume>
<fpage>304</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="doi">10.1080/07853890410030877</pub-id>
<pub-id pub-id-type="pmid">15224657</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Andrades</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frota Junior</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation</article-title>
<source>Intensive Care Med</source>
<year>2003</year>
<volume>29</volume>
<fpage>1782</fpage>
<lpage>1789</lpage>
<pub-id pub-id-type="doi">10.1007/s00134-003-1789-9</pub-id>
<pub-id pub-id-type="pmid">12783160</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodin</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Rodin</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Human lung cancer and p53: the interplay between mutagenesis and selection</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>2000</year>
<volume>97</volume>
<fpage>12244</fpage>
<lpage>12249</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.180320897</pub-id>
<pub-id pub-id-type="pmid">11035769</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roebuck</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lakshminarayanan</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>H
<sub>2</sub>
O
<sub>2</sub>
and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter</article-title>
<source>J Biol Chem</source>
<year>1995</year>
<volume>270</volume>
<fpage>18966</fpage>
<lpage>18974</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.32.18966</pub-id>
<pub-id pub-id-type="pmid">7642556</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothwarf</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Zandi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Natoli</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex</article-title>
<source>Nature</source>
<year>1998</year>
<volume>395</volume>
<fpage>297</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="doi">10.1038/26261</pub-id>
<pub-id pub-id-type="pmid">9751060</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saccani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pantano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Natoli</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Modulation of NF-kappaB activity by exchange of dimers</article-title>
<source>Mol Cell</source>
<year>2003</year>
<volume>11</volume>
<fpage>1563</fpage>
<lpage>1574</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(03)00227-2</pub-id>
<pub-id pub-id-type="pmid">12820969</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadikot</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yull</surname>
<given-names>FE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia</article-title>
<source>J Immunol</source>
<year>2004</year>
<volume>172</volume>
<fpage>1801</fpage>
<lpage>1808</lpage>
<pub-id pub-id-type="pmid">14734763</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanceau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kaisho</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors</article-title>
<source>J Biol Chem</source>
<year>1995</year>
<volume>270</volume>
<fpage>27920</fpage>
<lpage>27931</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.46.27920</pub-id>
<pub-id pub-id-type="pmid">7499267</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasco</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Secretan</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Straif</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Tobacco smoking and cancer: a brief review of recent epidemiological evidence</article-title>
<source>Lung Cancer</source>
<year>2004</year>
<volume>45</volume>
<issue>suppl 2</issue>
<fpage>S3</fpage>
<lpage>S9</lpage>
<pub-id pub-id-type="doi">10.1016/j.lungcan.2004.07.998</pub-id>
<pub-id pub-id-type="pmid">15552776</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ueki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hata</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium</article-title>
<source>J Histochem Cytochem</source>
<year>2008</year>
<volume>56</volume>
<fpage>97</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1369/jhc.7A7299.2007</pub-id>
<pub-id pub-id-type="pmid">17938282</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scagliotti</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Germonpre</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bosquee</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer</article-title>
<source>Lung Cancer</source>
<year>2010</year>
<volume>68</volume>
<fpage>420</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="doi">10.1016/j.lungcan.2009.07.011</pub-id>
<pub-id pub-id-type="pmid">19692142</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheinman</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Gualberto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jewell</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors</article-title>
<source>Mol Cell Biol</source>
<year>1995</year>
<volume>15</volume>
<fpage>943</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="pmid">7823959</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmeck</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zahlten</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moog</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor</article-title>
<source>J Biol Chem</source>
<year>2004</year>
<volume>279</volume>
<fpage>53241</fpage>
<lpage>53247</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M313702200</pub-id>
<pub-id pub-id-type="pmid">15485852</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmedtje</surname>
<given-names>JF</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Ji</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>WL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells</article-title>
<source>J Biol Chem</source>
<year>1997</year>
<volume>272</volume>
<fpage>601</fpage>
<lpage>608</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.272.1.601</pub-id>
<pub-id pub-id-type="pmid">8995303</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Multiple nuclear factors interact with the immunoglobulin enhancer sequences</article-title>
<source>Cell</source>
<year>1986</year>
<volume>46</volume>
<fpage>705</fpage>
<lpage>716</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(86)90346-6</pub-id>
<pub-id pub-id-type="pmid">3091258</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences</article-title>
<source>Mol Cell Biol</source>
<year>1987</year>
<volume>7</volume>
<fpage>1989</fpage>
<lpage>1994</lpage>
<pub-id pub-id-type="pmid">3110599</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shakhov</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Collart</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Vassalli</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages</article-title>
<source>J Exp Med</source>
<year>1990</year>
<volume>171</volume>
<fpage>35</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1084/jem.171.1.35</pub-id>
<pub-id pub-id-type="pmid">2104921</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The significance of the expression of endothelial ICAM-1 induced by LPS</article-title>
<source>Zhonghua Shao Shang Za Zhi</source>
<year>2002</year>
<volume>18</volume>
<fpage>279</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="pmid">12515639</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shenkar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yum</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Arcaroli</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interactions between CBP, NF-kappaB, and CREB in the lungs after hemorrhage and endotoxemia</article-title>
<source>Am J Physiol Lung Cell Mol Physiol</source>
<year>2001</year>
<volume>281</volume>
<fpage>L418</fpage>
<lpage>L426</lpage>
<pub-id pub-id-type="pmid">11435217</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shishodia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Nuclear factor-kappaB: a friend or a foe in cancer?</article-title>
<source>Biochem Pharmacol</source>
<year>2004</year>
<volume>68</volume>
<fpage>1071</fpage>
<lpage>1080</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2004.04.026</pub-id>
<pub-id pub-id-type="pmid">15313403</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shishodia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Potdar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gairola</surname>
<given-names>CG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1</article-title>
<source>Carcinogenesis</source>
<year>2003</year>
<volume>24</volume>
<fpage>1269</fpage>
<lpage>1279</lpage>
<pub-id pub-id-type="doi">10.1093/carcin/bgg078</pub-id>
<pub-id pub-id-type="pmid">12807725</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shishodia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gutierrez</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Lotan</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products</article-title>
<source>Cancer Res</source>
<year>2005</year>
<volume>65</volume>
<fpage>9555</fpage>
<lpage>9565</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1585</pub-id>
<pub-id pub-id-type="pmid">16230421</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Perfetti</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>King</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers</article-title>
<source>Inhal Toxicol</source>
<year>2006</year>
<volume>18</volume>
<fpage>667</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="doi">10.1080/08958370600742821</pub-id>
<pub-id pub-id-type="pmid">16864557</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sopori</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Effects of cigarette smoke on the immune system</article-title>
<source>Nat Rev Immunol</source>
<year>2002</year>
<volume>2</volume>
<fpage>372</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1038/nri803</pub-id>
<pub-id pub-id-type="pmid">12033743</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sovak</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Bellas</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer</article-title>
<source>J Clin Invest</source>
<year>1997</year>
<volume>100</volume>
<fpage>2952</fpage>
<lpage>2960</lpage>
<pub-id pub-id-type="doi">10.1172/JCI119848</pub-id>
<pub-id pub-id-type="pmid">9399940</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabakin-Fix</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huleihel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aboud</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Activation of simian virus 40 promoter by HTLV-I Tax protein: role of NF-κB and CBP</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2004</year>
<volume>318</volume>
<fpage>1052</fpage>
<lpage>1056</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2004.04.137</pub-id>
<pub-id pub-id-type="pmid">15147980</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shishodia</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions</article-title>
<source>Cancer</source>
<year>2006</year>
<volume>107</volume>
<fpage>2637</fpage>
<lpage>2646</lpage>
<pub-id pub-id-type="doi">10.1002/cncr.22315</pub-id>
<pub-id pub-id-type="pmid">17078054</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luxon</surname>
<given-names>BA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of NF-κB-dependent gene networks in respiratory syncytial virus-infected cells</article-title>
<source>J Virol</source>
<year>2002</year>
<volume>76</volume>
<fpage>6800</fpage>
<lpage>6814</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.76.13.6800-6814.2002</pub-id>
<pub-id pub-id-type="pmid">12050393</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lin-Shiau</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol</article-title>
<source>Br J Pharmacol</source>
<year>1999</year>
<volume>126</volume>
<fpage>673</fpage>
<lpage>680</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjp.0702357</pub-id>
<pub-id pub-id-type="pmid">10188978</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanden Berghe</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Plaisance</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boone</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor</article-title>
<source>J Biol Chem</source>
<year>1998</year>
<volume>273</volume>
<fpage>3285</fpage>
<lpage>3290</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.6.3285</pub-id>
<pub-id pub-id-type="pmid">9452444</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veale</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Needham</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Urokinase receptors in lung cancer and normal lung</article-title>
<source>Anticancer Res</source>
<year>1990</year>
<volume>10</volume>
<fpage>417</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="pmid">2161199</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venkataraman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Burakoff</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells</article-title>
<source>J Exp Med</source>
<year>1995</year>
<volume>181</volume>
<fpage>1091</fpage>
<lpage>1099</lpage>
<pub-id pub-id-type="doi">10.1084/jem.181.3.1091</pub-id>
<pub-id pub-id-type="pmid">7532676</pub-id>
</element-citation>
</ref>
<ref id="CR172">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vermeulen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>De Wilde</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Van Damme</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)</article-title>
<source>EMBO J</source>
<year>2003</year>
<volume>22</volume>
<fpage>1313</fpage>
<lpage>1324</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/cdg139</pub-id>
<pub-id pub-id-type="pmid">12628924</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voortman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Checinska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giaccone</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non-small cell lung cancer cell line NCI-H460</article-title>
<source>Mol Cancer Ther</source>
<year>2007</year>
<volume>6</volume>
<fpage>1046</fpage>
<lpage>1053</lpage>
<pub-id pub-id-type="doi">10.1158/1535-7163.MCT-06-0577</pub-id>
<pub-id pub-id-type="pmid">17363497</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Baldwin</surname>
<given-names>AS</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529</article-title>
<source>J Biol Chem</source>
<year>1998</year>
<volume>273</volume>
<fpage>29411</fpage>
<lpage>29416</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.45.29411</pub-id>
<pub-id pub-id-type="pmid">9792644</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Effect of NF-κB signaling on apoptosis in chronic inflammation-associated carcinogenesis</article-title>
<source>Curr Cancer Drug Targets</source>
<year>2010</year>
<volume>10</volume>
<fpage>593</fpage>
<lpage>599</lpage>
<pub-id pub-id-type="doi">10.2174/156800910791859425</pub-id>
<pub-id pub-id-type="pmid">20482486</pub-id>
</element-citation>
</ref>
<ref id="CR176">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barke</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Charboneau</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Morphine induces defects in early response of alveolar macrophages to
<italic>Streptococcus pneumoniae</italic>
by modulating TLR9-NF-kappa B signaling</article-title>
<source>J Immunol</source>
<year>2008</year>
<volume>180</volume>
<fpage>3594</fpage>
<lpage>3600</lpage>
<pub-id pub-id-type="pmid">18292587</pub-id>
</element-citation>
</ref>
<ref id="CR177">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Flaherty</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Carskadon</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis</article-title>
<source>Clin Cancer Res</source>
<year>2003</year>
<volume>9</volume>
<fpage>853</fpage>
<lpage>860</lpage>
<pub-id pub-id-type="pmid">12576459</pub-id>
</element-citation>
</ref>
<ref id="CR178">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>DuBois</surname>
<given-names>RN</given-names>
</name>
</person-group>
<article-title>The role of cyclooxygenases in inflammation, cancer, and development</article-title>
<source>Oncogene</source>
<year>1999</year>
<volume>18</volume>
<fpage>7908</fpage>
<lpage>7916</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1203286</pub-id>
<pub-id pub-id-type="pmid">10630643</pub-id>
</element-citation>
</ref>
<ref id="CR179">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wislez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Izzo</surname>
<given-names>JG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras</article-title>
<source>Cancer Res</source>
<year>2006</year>
<volume>66</volume>
<fpage>4198</fpage>
<lpage>4207</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3842</pub-id>
<pub-id pub-id-type="pmid">16618742</pub-id>
</element-citation>
</ref>
<ref id="CR180">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wissink</surname>
<given-names>S</given-names>
</name>
<name>
<surname>van Heerde</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor</article-title>
<source>J Biol Chem</source>
<year>1997</year>
<volume>272</volume>
<fpage>22278</fpage>
<lpage>22284</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.272.35.22278</pub-id>
<pub-id pub-id-type="pmid">9268377</pub-id>
</element-citation>
</ref>
<ref id="CR181">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woronicz</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK</article-title>
<source>Science</source>
<year>1997</year>
<volume>278</volume>
<fpage>866</fpage>
<lpage>869</lpage>
<pub-id pub-id-type="doi">10.1126/science.278.5339.866</pub-id>
<pub-id pub-id-type="pmid">9346485</pub-id>
</element-citation>
</ref>
<ref id="CR182">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Harhaj</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100</article-title>
<source>Mol Cell</source>
<year>2001</year>
<volume>7</volume>
<fpage>401</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(01)00187-3</pub-id>
<pub-id pub-id-type="pmid">11239468</pub-id>
</element-citation>
</ref>
<ref id="CR183">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation</article-title>
<source>J Biol Chem</source>
<year>2004</year>
<volume>279</volume>
<fpage>30099</fpage>
<lpage>30105</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M401428200</pub-id>
<pub-id pub-id-type="pmid">15140882</pub-id>
</element-citation>
</ref>
<ref id="CR184">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gaynor</surname>
<given-names>RB</given-names>
</name>
</person-group>
<article-title>Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer</article-title>
<source>J Clin Invest</source>
<year>2001</year>
<volume>107</volume>
<fpage>135</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1172/JCI11914</pub-id>
<pub-id pub-id-type="pmid">11160126</pub-id>
</element-citation>
</ref>
<ref id="CR185">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaoka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Courtois</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bessia</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation</article-title>
<source>Cell</source>
<year>1998</year>
<volume>93</volume>
<fpage>1231</fpage>
<lpage>1240</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81466-X</pub-id>
<pub-id pub-id-type="pmid">9657155</pub-id>
</element-citation>
</ref>
<ref id="CR186">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>XD</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit</article-title>
<source>EMBO J</source>
<year>2009</year>
<volume>28</volume>
<fpage>1055</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="doi">10.1038/emboj.2009.55</pub-id>
<pub-id pub-id-type="pmid">19262565</pub-id>
</element-citation>
</ref>
<ref id="CR187">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Balch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kulp</surname>
<given-names>SK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A rationally designed histone deacetylase inhibitor with distinct antitumor activity against ovarian cancer</article-title>
<source>Neoplasia</source>
<year>2009b</year>
<volume>11</volume>
<fpage>552</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="pmid">19484144</pub-id>
</element-citation>
</ref>
<ref id="CR188">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Kode</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Redox regulation of lung inflammation: role of NADPH oxidase and NF-κB signalling</article-title>
<source>Biochem Soc Trans</source>
<year>2007</year>
<volume>35</volume>
<issue>Pt 5</issue>
<fpage>1151</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="pmid">17956299</pub-id>
</element-citation>
</ref>
<ref id="CR189">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Edirisinghe</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice</article-title>
<source>Am J Pathol</source>
<year>2008</year>
<volume>172</volume>
<fpage>1222</fpage>
<lpage>1237</lpage>
<pub-id pub-id-type="doi">10.2353/ajpath.2008.070765</pub-id>
<pub-id pub-id-type="pmid">18403597</pub-id>
</element-citation>
</ref>
<ref id="CR190">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>CJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer</article-title>
<source>Am J Respir Crit Care Med</source>
<year>2000</year>
<volume>162</volume>
<fpage>1957</fpage>
<lpage>1963</lpage>
<pub-id pub-id-type="pmid">11069840</pub-id>
</element-citation>
</ref>
<ref id="CR191">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zandi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rothwarf</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Delhase</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation</article-title>
<source>Cell</source>
<year>1997</year>
<volume>91</volume>
<fpage>243</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80406-7</pub-id>
<pub-id pub-id-type="pmid">9346241</pub-id>
</element-citation>
</ref>
<ref id="CR192">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Frei</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo</article-title>
<source>Free Radic Biol Med</source>
<year>2009</year>
<volume>46</volume>
<fpage>791</fpage>
<lpage>798</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.12.003</pub-id>
<pub-id pub-id-type="pmid">19124074</pub-id>
</element-citation>
</ref>
<ref id="CR193">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>SuYang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Erdjument-Bromage</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism</article-title>
<source>Cell</source>
<year>1997</year>
<volume>89</volume>
<fpage>413</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80222-6</pub-id>
<pub-id pub-id-type="pmid">9150141</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000367 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000367 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:7079756
   |texte=   Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:21786215" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021